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ABSTRACT 
 
Clostridium botulinum, the causative agent of botulism in humans and animals, is 
frequently exposed to stressful environments during its growth in food or colonization of a 
host body. The wide genetic diversity of the strains of this foodborne pathogen has been 
thoroughly studied using different molecular biological methods; however, it is still 
largely unknown how this diversity reflects in the ability of different C. botulinum strains 
to tolerate environmental stresses. In contrast to cold tolerance, which has been the focus 
of intensive research in recent years, the molecular mechanisms C. botulinum utilizes in 
response to heat shock and during adaptation to high temperature stress are poorly 
understood. The aims of this study were to investigate the strain variation of Group I and 
II C. botulinum with regard to growth at low, high, and optimal temperature; the roles of 
hrcA, the negative regulator of Class I heat shock genes (HSG) and dnaK, a molecular 
chaperone coding Class I HSG, in the response of the Group I C. botulinum strain 
ATCC 3502 to heat and other environmental stresses; and the molecular mechanisms this 
strain employs in response to acute and prolonged heat stress. 
The maximum and minimum growth temperatures of 23 Group I and 24 Group II C. 
botulinum strains were studied. Further, maximum growth rates of the Group I strains at 
20, 37, and 42 °C and of the Group II strains at 10, 30, 37, and 42 °C were determined. 
Within their groups, the C. botulinum strains showed significant variation in growth-
limiting temperatures and their capability to grow at extreme temperature, especially at 
high temperature. Largest strain variation was found for Group I within type B and for 
Group II within type E strains, which further showed more mesophilic growth tendencies 
than the other Group II strains. However, the genetic background of the selected C. 
botulinum strains reflected only weakly in their growth characteristics. Group I strains 
showed larger physiological variation despite being genetically more closely related than 
Group II. A number of strains of both groups showed faster growth at temperatures above 
than at their commonly assumed optimal growth temperatures of 30 °C for Group II and 
37 °C for Group I strains. In addition, they possessed higher maximum growth 
temperatures than the average of the studied strains. These strains can be expected to have 
higher than assumed optimal growth temperatures and pronounced high temperature stress 
tolerance. Good correlation was detected between maximum growth temperatures and 
growth rates at high temperature, although not for all strains. Therefore direct prediction 
from one studied growth trait to the other was impossible. These findings need to be taken 
into account when estimating the safety of food products with regard to C. botulinum by 
risk assessment and challenge studies. 
The role of Class I HSGs in C. botulinum Group I strain ATCC 3502 was studied by 
quantitative real-time reverse transcription PCR and insertional inactivation of the Class I 
HSGs hrcA and dnaK. During exponential and transitional growth, Class I HSGs were 
constantly expressed followed by down-regulation in the stationary phase. Exposure of 
mid-exponentially growing culture to heat shock led to strong, transient Class I HSG up-
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regulation. Inactivation of hrcA resulted in over-expression of all Class I HSGs, which 
confirmed its role as negative regulator of Class I HSGs in C. botulinum. Both inactivation 
mutants showed impaired high temperature tolerance as indicated by reduced growth rates 
at 45 °C, a reduced maximum growth temperature, and increased log-reduction after 
exposure to lethal temperature. The growth of the dnaK mutant was more strongly affected 
than that of the hrcA mutant, emphasizing the importance of the molecular chaperone 
DnaK for C. botulinum. Reduced growth rates were evident for both mutants under 
optimal conditions and heat stress, but also under low pH, and high saline concentration. 
This suggests a probable role for Class I HSG in cross protection of C. botulinum against 
other environmental stresses.  
C. botulinum ATCC 3502 was grown in continuous culture and exposed to heat shock 
followed by prolonged high temperature stress at 45 °C. Changes in the global gene 
expression pattern induced by heat stress were investigated using DNA microarray 
hybridization. Class I and III HSGs, as well as members of the SOS regulon, were 
employed in response to acute heat stress. High temperature led to suppression of the 
botulinum neurotoxin coding botA and the associated non-toxic protein-coding genes. 
During adaptation and in the heat-adapted culture, motility- and chemotaxis-related genes 
were found to be up-regulated, whereas sporulation related genes were suppressed. Thus, 
increase in motility appeared to be the long-term high-temperature stress-response 
mechanism preferred to sporulation. Prophage genes, including regulatory genes, were 
activated by high temperature and might therefore contribute to the high temperature 
tolerance of C. botulinum strain ATCC 3502. Further, remodeling of parts of the protein 
metabolism and changes in carbohydrate metabolism were observed.  
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1. INTRODUCTION  
 
Clostridium is a genus of Gram-positive, rod-shaped, obligate anaerobe, endospore-
forming bacteria which is widespread in nature. The genus includes a number of highly 
pathogenic, toxin-producing species (Hatheway, 1990), the most important of which are: 
Clostridium perfringens, the cause of histotoxic and enteric diseases; C. difficile, the cause 
of the emerging antibiotic-associated pseudomembranous colitis; C. tetani, the cause of 
tetanus; and C. botulinum, the cause of the different forms of botulism (Hatheway, 1990). 
This study focuses on the C. botulinum.  
The botulinum neurotoxin (BoNT) forming C. botulinum has first been 
epidemiologically linked to a foodborne intoxication in 1895/1896 when van Ermengem, a 
Belgian professor of bacteriology at the University of Ghent, was able to isolate a Gram-
positive, anaerobic, spore-forming organism from smoked ham as well as deceased 
participants of a funeral at which this ham was served (Ermengem, 1897; Erbguth, 2004; 
Erbguth, 2008). The affected people had died after developing symptoms of a disease 
commonly called “sausage poisoning”. He called the bacterium Bacillus botulinus (from 
the Latin word botulus, meaning “sausage”) (Ermengem, 1897; Torrens, 1998); later it 
was renamed to C. botulinum. The “sausage poisoning”, a paralytic, potentially-lethal 
disease, had emerged strongly in the late 18th and early 19th century in the German 
Kingdom of Württemberg and was soon connected to smoked blood-sausages that had 
been prepared under poor hygienic conditions and were often under-cooked. The first two 
detailed clinical descriptions were published in 1817 by Steinbuch and by Kerner (Erbguth 
& Naumann, 1999; Erbguth, 2009). The latter further conducted pioneering scientific 
experiments and was able to induce symptoms of botulism in different animals and 
himself using extracts of spoiled sausages (Kerner, 1822). This led him to the conclusion 
that the substance in question was a toxin. He further speculated a potential therapeutic 
use of this poison in the treatment of neurological diseases (Kerner, 1822). Although 
initially thought to be related to animal products only, botulism was observed after the 
consumption of canned vegetables and the first environmental strains of C. botulinum 
were isolated (Burke, 1919a; Erbguth, 2009). In addition to the above-described foodborne 
form of botulism, which is intoxication with BoNT, infections with C. botulinum can lead 
to in situ toxin production, namely infant, intestinal and wound botulism (Hatheway, 
1990; Sobel, 2005). 
Even though food contaminated with BoNT has been linked to botulism for 
approximately 200 years, foodborne botulism still poses a substantial hazard to human 
health in modern times (Lindström & Korkeala, 2006; Lindström et al., 2006; Peck et al., 
2011; Carter & Peck, 2015). Due to limited possibilities to treat clinical botulism (Sobel, 
2005), and the high toxicity of BoNT, the only way to prevent the disease is to ensure the 
absence of BoNT in food. Many efforts have been made to control and to prevent growth 
of C. botulinum in food. In the early days, rising public awareness and recommendations 
of outbreak control were the first attempts to reduce the number of botulism cases (Thom, 
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1922; Hall, 1943). Later, the introduction of the botulinum cook in the canning industry to 
reduce spore numbers led to a significant decrease in outbreaks caused by commercial 
products (Stumbo et al., 1975; Peck, 2009; Setlow & Johnson, 2013; Dahlsten et al., 
2015). Today, challenge studies, predictive modelling, and modern risk assessment, as 
well as hurdle technology of mildly-processed convenient foods are some of the methods 
employed to ensure food safety with regard to botulism (Juneja & Marks, 1999; Lindström 
et al., 2006; Peck, 2006; Peck et al., 2008; Anderson et al., 2011; Ihekwaba et al., 2016; 
Ihekwaba et al., 2016). Nevertheless, outbreaks of botulism are still frequently reported, 
and a number of them are caused by commercial products (Sobel et al., 2004; Lindström 
& Korkeala, 2006; Centers for Disease Control and Prevention (CDC), 2011; Daminelli et 
al., 2011; Jalava et al., 2011; Carter & Peck, 2015) 
Differences between C. botulinum strains were first observed when antitoxins produced 
against one strain failed to protect animals against another, as the strains produced 
serologically distinct toxins. This led to the distinction of different C. botulinum serotypes 
(Burke, 1919b). Further, heterogeneity in their physiology, especially in cell metabolism 
and nutrient requirements, was identified and the strains were later separated into different 
groups (Holdeman & Brooks, 1970; Hatheway, 1990). Even though strain variation within 
these groups (growth temperature and toxin formation) has been reported (Jensen et al., 
1987) and the wide genetic diversity of C. botulinum has been recognized (Hielm et al., 
1998a; Hyytia et al., 1999; Keto-Timonen et al., 2005; Nevas et al., 2005; Hill et al., 
2015; Williamson et al., 2016), little is known about strain variation within groups of 
C. botulinum with regard to growth temperatures (Stringer et al., 2013). Chill temperature 
is one of the most important hurdles to prevent growth of C. botulinum especially in 
minimally-processed foods, whereas high temperature stress is frequently experienced by 
foodborne pathogens during food preparation and preservation. Therefore variation in the 
temperature stress tolerance of different C. botulinum strains can have a substantial impact 
on food safety and its assessment. The impact of cold stress on C. botulinum and the 
molecular mechanisms the bacterium employs have been recently studied thoroughly 
(Söderholm et al., 2011; Lindström et al., 2012; Dahlsten et al., 2014; Dahlsten et al., 
2014; Mascher et al., 2014; Söderholm et al., 2015). However, little is known about the 
molecular basis of heat stress response in C. botulinum to date (Shukla & Singh, 1999; 
Shukla & Singh, 2009; Liang et al., 2013). Deeper knowledge on strain variation of 
C. botulinum and better understanding of its stress-response mechanisms are therefore 
needed to enhance food safety with regard to this challenging pathogen.  
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2. REVIEW OF THE LITERATURE 
 
 
2.1. Clostridium botulinum and botulism 
 
2.1.1. Clostridium botulinum 
 
Organism. Clostridium botulinum belongs to the genus Clostridium of the phylum 
Firmicutes. Clostridia are a group of Gram-positive, rod-shaped, low G+C 
deoxyribonucleic acid (DNA)-containing, motile, obligate anaerobe bacteria, which can 
form heat-resistant endospores (Cato et al., 1986). The bacterium is of a ubiquitous nature, 
spores of C. botulinum are commonly found in soil and aquatic environments in many 
parts of the world (Hauschild, 1989). The denominating feature of all strains of the species 
C. botulinum is their ability to form botulinum neurotoxin (BoNT) during vegetative 
growth, the causative agent of a rare, but potentially-lethal neuroparalytic disease called 
botulism, affecting humans and animals (Prévot, 1953; Hatheway, 1990). Strains of 
C. botulinum are being assigned to the serotypes A-G due to the serological properties of 
the produced BoNT and separated due to their physiological and metabolic characteristics 
into Group I-IV (Hatheway, 1990).  
C. botulinum strains typically carry one neurotoxin-coding gene and therefore express 
one BoNT serotype. However, bivalent strains carrying two active neurotoxin genes (Ab, 
Af, Ba, and Bf) (Peck, 2009; Hill & Smith, 2013), and one strain harboring even three 
(A2f4f5) (Dover et al., 2013; Kalb et al., 2014), have been described. These multiple 
neurotoxin-gene-carrying strains predominantly form toxin of one serotype, the major 
toxin, indicated by an upper case letter, and only small amounts of active minor toxin, 
indicated by a lower case letter. The second neurotoxin gene can also remain unexpressed, 
thus be silent, which is indicated with brackets in such cases.  
The obvious diversity and heterogeneity of the species warranted the differentiation of 
C. botulinum strains into groups, based on their physiological behavior (Holdeman & 
Brooks, 1970). To date, BoNT-producing clostridia are separated into six groups of which 
Groups I to IV consist of C. botulinum strains, whereas BoNT producing Clostridium 
butyricum and Clostridium baratii strains form their own groups (Hatheway, 1990) (Table 
1). These phenotypical groups also reflect the phylogenetic background of C. botulinum 
strains, which has been underlined by studies using molecular typing, DNA sequencing 
(16S ribosomal ribonucleic acid), and DNA hybridization methods (Suen et al., 1988; 
Hutson et al., 1993; Collins et al., 1994; Keto-Timonen et al., 2005; Hill et al., 2007). The 
availability of genomic data for a growing number of C. botulinum strains, as well as 
analyses of strains by comparative genomic hybridization using DNA microarrays, have 
provided deeper insight into the C. botulinum phylogeny (Hill et al., 2007; Carter et al., 
2009; Lindström et al., 2009; Carter & Peck, 2015; Hill et al., 2015; Williamson et al., 
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2016). These studies have shown relatively close relatedness within, and high diversity 
between, the groups. This further fueled the discussion about C. botulinum nomenclature 
and the question of whether the groups should in fact be assigned to different species, as 
already proposed when Suen et al. suggested Group IV C. botulinum as the species 
C. argentinense (Suen et al., 1988; Collins & East, 1998; Peck, 2009).  
The groups of BoNT-producing clostridial strains most commonly related to human 
botulism are Group I (proteolytic C. botulinum) and II (non-protelytic C. botulinum), but 
cases caused by strains of Group V (C. butyricum) and VI (C. baratii) have also been 
reported. Group III strains have commonly been associated to botulism in animals and are 
therefore of economic importance when effecting production animals, whereas Group IV 
(C. argentinense) strains have never been shown to naturally induce disease. 
 
Physiology. The characteristic physiological properties of the different groups of BoNT 
producing clostridial strains are listed in Table 1. Given that Group I and II C. botulinum 
strains are accountable for the majority of human botulism cases, the characteristics of 
these two groups will be described here in more detail.  
All Group I and Group II C. botulinum strains are able to ferment glucose, liquefy 
gelatin, produce lipase, and degrade chitin (Carter & Peck, 2015).  
Group I C. botulinum is proteolytic, mesophilic, and forms spores extremely resistant to 
high temperatures and other environmental stresses like radiation, high pressure, and 
desiccation (Lindström & Korkeala, 2006; Peck, 2009; Johnson, 2013; Setlow & Johnson, 
2013). The group consists of strains producing BoNT serotypes A, B, and/or F; all bi- or 
trivalent strains discovered to date belong to this group (Peck, 2009; Dover et al., 2013; 
Hill & Smith, 2013). Proteolytic strains of C. botulinum have been linked to foodborne, 
wound, and also to intestinal/infant botulism. Cases of foodborne botulism caused by 
proteolytic strains most commonly involve home-canned meat and vegetables or 
commercial products intended to be stored at ambient temperature that had been exposed 
to process failure (Lindström & Korkeala, 2006; Peck, 2009).  
The main characteristic of Group I C. botulinum is its distinctive proteolytic activity, 
which differentiates it from Group II. Group I C. botulinum can utilize native protein 
sources for growth; it is able to digest casein, meat, and coagulated egg white, in addition 
to other substrates (Holdeman & Brooks, 1970; Hatheway, 1990). Indeed, sequencing the 
genome of the strain ATCC 3502 revealed the presence of several coding sequences 
(CDSs) for secreted proteases and a large number transporters related to peptide and 
amino acid uptake (Sebaihia et al., 2007). Differences in the ability of the various 
C. botulinum strains to ferment amino acids has been used to develop a polymerase chain 
reaction (PCR) based assay to distinguish Group I from Group II (Dahlsten et al., 2008). 
The organism is further able to metabolize selected amino acids in a coupled oxidation–
reduction reaction, the Stickland reaction (Stickland, 1934; Clifton, 1940; Sebaihia et al., 
2007). The main end products of its catabolism are acetate, butyrate, ammonia, carbon 
dioxide, hydrogen, and lactic acids (Clifton, 1940). The ability to ferment carbohydrates is 
limited and varies between strains. However, all  strains  are  reported  to  ferment  glucose  
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with ethanol and carbon dioxide as metabolic end products, whereas sucrose and mannose 
cannot be utilized (Clifton, 1940; Holdeman & Brooks, 1970; Carter & Peck, 2015). Even 
though carbohydrates can stimulate growth and toxin production of Group I C. botulinum, 
they are not essential for this bacterium (Siegel & Metzger, 1979; Siegel & Metzger, 1980; 
Whitmer & Johnson, 1988). 
Group I C. botulinum is considered to be a mesophile, with a commonly-assumed 
optimum growth temperature of 37 °C (Hatheway, 1993; Peck, 2009). The temperature 
range enabling growth and toxin formation of these strains is commonly reviewed to be 
between 10-12 °C and 48 °C (Ohye & Scott, 1953; Lynt et al., 1982; Hatheway, 1990; 
Johnson, 2000; Johnson, 2000; Peck et al., 2011; Johnson, 2013; Carter & Peck, 2015). 
However, although extensive studies evaluating a large number of Group I strains have 
never been performed, temperature limits for the growth of C. botulinum appear to vary 
between different strains (Bonventre & Kempe, 1959b; Jensen et al., 1987; Hauschild, 
1989; Hauschild, 1989; Johnson, 2000). The strains tolerate relatively low water activity. 
Provided otherwise optimal conditions, 10% NaCl in the water phase leading to a water 
activity of 0.94 is considered to be growth limiting (Lynt et al., 1982; Hauschild, 1989). 
An environmental pH of 4.6 is assumed to prevent growth of Group I C. botulinum (Peck, 
2009), although growth and toxin formation in a defined medium at a pH as low as 4.3 
have been reported (Nobumasa, 1982). 
In contrast to Group I, Group II C. botulinum is non-proteolytic, considered to be 
psychrotrophic, and forms spores substantially less resistant to heat than Group I spores 
(Lindström et al., 2006; Peck, 2009). Strains of Group II isolated until today produce a 
single BoNT of serotype B, F, or E and have been associated almost exclusively to 
foodborne botulism. Non-proteolytic C. botulinum is often related to outbreaks involving 
minimally processed, vacuum-packed, chilled, or traditionally-fermented foods, usually 
containing fish or meat (Lindström et al., 2006; Peck, 2006; Peck, 2009). 
The inability of Group II C. botulinum strains to utilize complex protein from milk or meat 
as an energy source (Holdeman & Brooks, 1970) is the basis for their denomination as 
non-proteolytic and this characteristic is employed when distinguishing them from 
proteolytic strains on casein based agars. However, several C. botulinum type E strains 
have been shown to possess some proteolytic activity as they are able to digest gelatin 
(Nakane & Iida, 1977). In contrast to Group I, growth of non-proteolytic C. botulinum 
strains depends on carbohydrates; they are able to ferment a wide range of carbohydrates 
like fructose, maltose, mannose, and sucrose (Holdeman & Brooks, 1970; Carter & Peck, 
2015) and are therefore considered saccharolytic. Acetate and butyrate are the main 
metabolites produced (Holdeman & Brooks, 1970; Peck, 2009). When studied by AFLP 
the genetic diversity within Group II C. botulinum was higher than within Group I (Keto-
Timonen et al., 2005), however, a recent study comparing a large number of C. botulinum 
genome sequences did not demonstrate a clear difference in the level of diversity of the 
two groups (Williamson et al., 2016). Serotype E strains form a subset distinct from the 
non-proteolytic serotype B and F strains (Keto-Timonen et al., 2005; Stringer et al., 2013), 
which reflects to some degree in their saccharolytic activity (Stringer et al., 2013).   
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Being psychotrophic, Group II C. botulinum has a commonly-assumed optimum 
growth temperature of about 25-30 °C (Lindström et al., 2006; Peck, 2009; Carter & Peck, 
2015), with growth temperature limits of 3 °C and 45 °C (Eklund et al., 1967; Johnson, 
2000; Peck, 2009; Peck et al., 2011). Non-proteolytic C. botulinum strains are able to form 
toxin at temperatures as low as 3 °C after incubation for 5 to 6 weeks under otherwise 
optimal conditions (Eklund et al., 1967; Graham et al., 1997). As mentioned for Group I, 
Group II also shows strain variation with regard to growth temperature (Jensen et al., 
1987; Stringer et al., 2013). Group II C. botulinum appears to be less resistant to 
environmental stresses than Group I, with a water activity below 0.97 generated by 5% 
NaCl in the water phase or a pH below 5 prevent growth (Segner et al., 1966; Peck et al., 
2011). 
 
2.1.2. Botulinum neurotoxin  
 
Botulinum neurotoxin. The German physician Justinus Kerner was the first to describe 
BoNT as a poison in 1822: he proposed a “sausage poison”, or “fatty acid” derived from 
spoiled sausages, to be the cause of a potentially-lethal paralytic illness he was confronted 
with in his practice (Kerner, 1822; Erbguth & Naumann, 1999; Erbguth, 2004). He 
concluded from his observations and experimental studies that the toxin is produced under 
anaerobic conditions in spoiled sausages, that it is a biological substance, which affects 
motor neurons, and that it is very strong, lethal in even small doses. In 1896, van 
Ermengem was able to associate the poisoning to an anaerobic bacterium he isolated and 
he called the organism “Bacillus botulinus”, which was later renamed to C. botulinum 
(Ermengem, 1897; Erbguth, 2008). Today it is known that BoNT produced by 
C. botulinum and some strains of C. butyricum and C. baratii is one of the most toxic 
biological substances known to mankind: it is estimated that less than 100 ng can cause 
human death (Wright, 1955; Gill, 1982; Schantz & Johnson, 1992; Arnon et al., 2001; 
Peck, 2009). It is widely used in medical science as a therapeutic agent to treat 
neuromuscular disorders and in the cosmetic industry to reduce wrinkles (Schantz & 
Johnson, 1992; Mahant et al., 2000; Bigalke, 2013). But it also has a high potential to be 
abused as a bioterrorism agent and is therefore listed as a Category A critical biological 
agent by the U.S. Centers for Disease Control and Prevention (Centers for Disease Control 
and Prevention, 2000; Arnon et al., 2001). 
In 1919, after distinct serological properties of BoNTs from different C. botulinum 
isolates had been recognized, Burke designated BoNT serotypes A and B (Burke, 1919b). 
Antitoxin derived from animals immunized with BoNT serotype A (BoNT/A) did not 
protect against a number of the strains she studied; she named the heterologous toxin 
BoNT/B. To date seven different types of BoNT (A-G) have been identified. Recently, 
there has been a lively discussion about the discovery of a BoNT/H, which has finally 
been shown to be hybrid of serotypes A and F that can be fully neutralized by serotype A 
antitoxin in high doses or a combination of serotype A and F antitoxins (Barash & Arnon, 
2014; Dover et al., 2014; Johnson, 2014; Kalb et al., 2015; Maslanka et al., 2015; Fan 
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et al., 2016). Modern molecular biological methods allow a more precise assessment of 
the different serotypes, as many BoNT protein sequences as well as neurotoxin-coding 
gene sequences are available and have been analyzed (Hill & Smith, 2013). The different 
BoNT serotypes can differ from ~25-45% in nucleotide sequence and ~37-70% in amino-
acid sequence. Analysis of BoNT coding sequences in relation to the genetic background 
of C. botulinum strains led to the conclusion that BoNT genes have been introduced into 
the genome by horizontal gene transfer (Hill et al., 2007; Hill et al., 2007; Carter et al., 
2009). Knowledge of the sequences of the different BoNT coding genes further led to the 
development of a number of rapid PCR-based detection methods for C. botulinum with the 
ability to differentiate strains with different toxin serotypes (Franciosa et al., 1994; Hielm 
et al., 1996; Lindström et al., 2001; Lindström & Korkeala, 2006; Fach et al., 2009; 
Kirchner et al., 2010).  
Further sequence variation exists within the serotypes of BoNT, which can have impact 
on antibody binding and neutralization as well as detection (Smith et al., 2005; Hill & 
Smith, 2013). BoNTs of one serotype with a sequence variation of 2.5% at the amino acid 
level are commonly considered to be different subtypes (Smith et al., 2005; Carter et al., 
2009). However, many authors prefer to define a subtype by the genetic clade a BoNT 
clusters into (Chen et al., 2007; Hill et al., 2015). Of the BoNT serotypes relevant to 
human health, eight subtypes of BoNT/A (A1-A8), eight of BoNT/B (B1-B8), seven of 
BoNT/F (F1-F7), twelve of BoNT/E (E1-E12), and one BoNT/A-F hybrid (also discussed 
as serotype H) have been described (Hill et al., 2015; Kalb et al., 2015; Kull et al., 2015; 
Maslanka et al., 2015).  
The BoNT is formed during vegetative growth of C. botulinum as a single chain 
polypeptide of a molecular weight of approximately 150 kDa, which is heat labile and can 
be destroyed by heating to 80 °C for 5 min (Wright, 1955). It naturally forms a progenitor 
toxin complex of 300 to 900 kDa with several associated non-toxic proteins (ANTPs) 
named hemagglutinin (HA) and non-toxic non-HA (NTNH) (Chen et al., 1998). The 
genes coding for BoNT and ANTPs are localized in the neurotoxin gene cluster (NTC), 
which C. botulinum strains may carry in their genome and/or on a plasmid (Group I and 
II) or on a phage (Group III) (Brüggemann, 2005).  However, not all strains carry HA 
coding genes, some possess instead p47 and orfX1-X3 genes in their NTCs (Chen et al., 
2007; Jacobson et al., 2008; Connan et al., 2013; Hill et al., 2015). NTCs of strains 
carrying HA coding genes are denominated “ha cluster”, NTCs of strains carrying orfX 
genes are called “orfX cluster” (Fig.1). 
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Figure 1.  Simplified examples of some neurotoxin gene cluster arrangements 
 
 
The BoNT is activated by extracellular proteolysis through host proteases or 
endogenous bacterial proteases, leading to the mature di-chain holotoxin consisting of a  
~100 kDa heavy chain (HC) and a ~50 kDa light chain (LC) joined via a disulfide bond 
(DasGupta, 1989). The crystal structure of the BoNT/A has been solved and contributes to 
the understanding of the mode of action of BoNT (Lacy et al., 1998). Early studies 
identified BoNT toxicity to be related to acetylcholine (ACh) (Torda & Wolff, 1947; 
Burgen et al., 1949). The release of the neurotransmitter ACh at the neuromuscular 
junction is prevented by BoNT, leading to a pre-synaptic block, thus disrupting signal 
transduction. BoNT needs to perform a series of steps to achieve this (Simpson, 1980; 
Simpson, 2013). In cases of oral intoxication, BoNT crosses the epithelial cell barrier of 
the gastrointestinal tract through an endocytosis-dependent mechanism to enter the 
bloodstream prior migration to its target cells, the motor neurons (Couesnon et al., 2008; 
Connan et al., 2015). The subsequent interaction of BoNT with motor neurons has been 
intensively studied and recently thoroughly reviewed (Aoki & Guyer, 2001; Poulain et al., 
2008; Binz, 2013; Fischer, 2013). Briefly, BoNT first needs to enter the neuron, which 
takes place by receptor-mediated endocytosis. The C-terminal binding domain of the HC 
interacts with the cell surface by binding to a surface ganglioside and a glycoprotein. In 
the acidic environment of the endosome, the HC N-terminal translocation region then 
forms a cation selective protein-conducting channel, which allows translocation of the 
unfolded LC into the cytosol. There the LC releases from the HC, refolds and can 
establish its zinc-dependent endopeptidase activity. The protease specifically cleaves 
soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE), which 
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are important for neurotransmitter exocytosis. The LC of the different serotypes have been 
shown to be substrate specific; BoNT/A, C, and E cleave synaptosomal associated  protein  
of  25 kDa  (SNAP-25), whereas  BoNT/B, D, F, and G cleave the synaptic integral 
vesicle associated membrane  protein (VAMP), also called synaptobrevin. BoNT/C is 
additionally able to cleave syntaxin, another synaptic membrane SNARE protein. The 
cleavage site within the SNAREs is also serotype specific, resulting in cleavage products 
of different sizes. This serotype specificity has been utilized to develop endopeptidase 
assays for sensitive BoNT detection (Hallis et al., 1996; Jones et al., 2008). Regardless of 
target protein and cleavage site, the activity of BoNT in the motor neuron prevents binding 
of the synaptic vesicles containing ACh and therefore inhibits release of this 
neurotransmitter into the neuromuscular junction. This disruption of ACh release from 
motor neurons leads to the typical clinical sign of botulism, flaccid paralysis without loss 
of consciousness.  
Even though BoNT can be lethal, its potential for medical use has been part of 
botulinum research from the beginning as already Kerner 1822 carefully hypothesized the 
application of BoNT to treat neurological diseases (Kerner, 1822; Erbguth & Naumann, 
1999; Erbguth, 2004). A big step towards the therapeutic use of BoNT was the 
development of a method to concentrate and crystallize BoNT/A by precipitation, 
although this research was originally intending the development of an efficient bioweapon 
(Lamanna et al., 1946; Scott, 2004). Nevertheless, purified BoNT/A provided the basis for 
all studies of the clinical use of the bacterial neurotoxin. Initially BoNT/A was used 
experimentally to treat strabismus in monkeys and later humans by local injections into 
the eye muscles (Scott, 1980). But the ability of BoNT to disrupt signal transduction at the 
neuromuscular junction, thus to paralyze selected muscles when locally administered, is 
today widely used to treat a number of diseases like strabismus, dystonia, cerebral palsy, 
blepharospasm, torticollis, and other muscular disorders (Schantz & Johnson, 1992; 
Mahant et al., 2000; Scott, 2004). Further BoNT/A can be used cosmetically to treat 
wrinkles, which has developed into a major business. Lately the toxin’s potential analgetic 
effect is a new focus in clinical BoNT research, as it has shown to be effective for those 
suffering chronic neuropathic pain and for migraine treatment (Silberstein et al., 2000; Cui 
et al., 2004; Ranoux et al., 2008). Despite its status as the most toxic naturally-occurring 
substance, BoNT is considered to be a safe therapeutic (Naumann & Jankovic, 2004; 
Bigalke, 2013).  
 
Regulation of BoNT expression. BoNT expression is a highly energy consuming 
mechanism for C. botulinum, therefore its regulation can be expected to be tightly 
controlled in the bacterium. Full characterization of this regulation would be a significant 
contribution to long-term aims of botulinum research: control and prevention of BoNT 
production in food and the human body, as well as improvement of BoNT quality and 
production for medical use. During vegetative growth in batch cultures the expression of 
BoNT is growth-phase dependent and begins at the onset of exponential growth with a 
strong increase during late exponential growth and transition phase (Bradshaw et al., 
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2004; Couesnon et al., 2006; Chen et al., 2008). The transcription of the NTC follows this 
pattern, peaking in the transition phase. Growth of C. botulinum and BoNT expression are 
affected by environmental conditions like nutrient availability, environmental pH, salt, 
temperature and other factors, which have been intensively studied to improve culture 
conditions to enhance toxin yield in (industrial) fermentations as well as to understand its 
role as a foodborne pathogen (Bonventre & Kempe, 1959a; Bonventre & Kempe, 1959b; 
Bonventre & Kempe, 1960; Segner et al., 1966; Eklund et al., 1967; Siegel & Metzger, 
1979; Siegel & Metzger, 1980; Whitmer & Johnson, 1988; Couesnon et al., 2006). With 
modern molecular biological tools becoming available, a growing number of publications 
try to elucidate the molecular bases of the regulation of BoNT expression, as recently 
reviewed by Connan et al. and Carter et al. (Connan et al., 2013; Carter et al., 2014). 
A major step in understanding the molecular mechanisms of BoNT regulation was the 
discovery of BotR, a positive regulator of NTC genes in C. botulinum type A (Hauser 
et al., 1994; Marvaud et al., 1998). BotR, being considered the key regulatory factor for 
NTC transcription, is an alternative sigma factor, highly related to TetR of C. tetani; it 
binds as a subunit to RNA polymerase core enzyme and promotes transcription of the 
NTC operon genes by -35 and -10 region recognition in its target promoters (Raffestin 
et al., 2005). Interestingly, serotype E and some type F strains lack the botR gene in their 
NTC operon (Chen et al., 2007; Dover et al., 2011).   
Two-component signal transduction systems (TCSs) are specialized mechanisms to 
sense the bacterial environment and induce a subsequent response. They consist of a 
membrane-located sensor histidine kinase and a cytoplasmic response regulator, usually a 
DNA-binding protein that regulates target gene expression. An environmental stimulus 
leads to autophosphorylation of the sensor that then phosphorylates its specific response 
regulator, which typically changes its DNA binding activity. As TCSs have been shown to 
play a role in virulence of many bacteria (Beier & Gross, 2006), their relation to BoNT/A 
expression has recently been systematically studied in C. botulinum (Connan et al., 2012; 
Zhang et al., 2013). Using the mRNA antisense method, it was discovered that at least 
three TCSs positively control BoNT/A expression in a botR-independent manner (Connan 
et al., 2012). Further, it was demonstrated that the TCS system CBO0787/CBO0786 
directly suppresses expression of the BoNT/A, as well as ANTP coding genes; it was 
shown that the response regulator CBO0786 binds to promotor regions in the NTC (Zhang 
et al., 2013). Thus far, this is the only discovered negative regulator of BoNT/A synthesis.   
The association of BoNT expression to the availability of certain nutrients in the 
bacterial environment was described during early investigations into C. botulinum 
(Bonventre & Kempe, 1959a; Boroff & DasGupta, 1971; Patterson-Curtis & Johnson, 
1989). Control of BoNT synthesis might therefore be tightly linked to nutritional signals 
and metabolic pathways, as are many virulence factors in other pathogenic bacteria 
(Dineen et al., 2007; Richardson et al., 2015). It has been recently shown that CodY, a 
global regulator of the transition from exponential to stationary phase, positively regulates 
BoNT gene expression in C. botulinum (Zhang et al., 2014). CodY protein is thought to 
directly regulate BoNT expression, as it interacts in a guanosine-triphosphate (GTP) 
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dependent manner with the BoNT gene promotor region. The enhancement of CodY 
binding to the promotor region by GTP led the authors to the conclusion, that CodY-
regulated BoNT expression is linked to the nutritional status of the cell, reflecting in 
intracellular GTP concentration, and that it might be associated to pyruvate metabolism 
(Zhang et al., 2014). 
Since BoNT expression is growth-phase dependent, an association to cell density seems 
likely. Quorum sensing is a process that allows bacteria to monitor the cell density by the 
means of signaling molecule concentration in their environment and to adjust their cellular 
behavior in accordance to it (Waters & Bassler, 2005). It is involved in the regulation of 
virulence in different bacteria (Winzer & Williams, 2001). In C. botulinum, the agr-2 
locus, coding for proteins related to the Staphylococcus aureus agr quorum sensing 
system, has been linked to the regulation of BoNT expression, as its inactivation resulted 
in decreased BoNT/A levels (Cooksley et al., 2010).  
 
2.1.3. Botulism 
 
Botulism is a rare, often severe neuroparalytic disease characterized by flaccid paralysis 
due to disruption of signal transduction at the neuromuscular junction caused by BoNT 
intoxication in mammals and birds. Typical symptoms often start with blurred vision, 
difficulties to swallow and speak, followed by descending paralysis and muscle weakness; 
decrease of lacrimation and secretion from the salivary glands, gastrointestinal and bladder 
paralysis are also commonly described (Sobel, 2005; Erbguth, 2008; Peck, 2009). If 
untreated, flaccid paralysis of respiratory and cardiac muscles might lead to death. 
Differential diagnoses include Guillain-Barré syndrome, Miller-Fisher syndrome, 
chemical intoxication, and stroke. Since only BoNT circulating in the bloodstream can be 
neutralized by intravenous injection of specific antitoxin, the treatment of the disease often 
relies on intensive additional palliative care, in very severe cases mechanical ventilation.  
Recovery from the disease takes a long time. The function of paralyzed synapses is 
temporally replaced by newly sprouting cells before the activity in the parental neurons is 
restored (Meunier et al., 2003). The time until full recovery is dependent on the BoNT 
serotype and dose and may take a couple of weeks to several months, cases requiring 
mechanical ventilation for more than a year have been reported (Sheth et al., 2008). 
Different forms of botulism have been described, and even though their clinical symptoms 
are very similar, they differ in their pathogenesis (Sobel, 2005). The classical foodborne 
botulism is intoxication with BoNT formed by vegetative C. botulinum in food. In 
contrast, wound, infant, and intestinal botulism are toxicoinfections, infections with C. 
botulinum forming BoNT in the human body. Further the iatrogenic botulism after 
therapeutic and cosmetic use of BoNT (Bakheit et al., 1997; Chertow et al., 2006) and 
potential inhalational botulism (Park & Simpson, 2003), both intoxications, have been 
described. Botulism in animals is usually the result of intoxication with BoNT and 
resembles foodborne botulism. However, C. botulinum may also colonize the animal’s 
intestine. If this intestinal form is caused by strains of Group I or Group II, it may be of 
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concern for human health if food products derived from an infected animal get 
contaminated (Lindström et al., 2010). The most common forms -foodborne, infant and 
wound botulism- are described here in more detail. 
 
Foodborne botulism. Intake of BoNT formed by toxigenic C. botulinum culture in food 
leads to foodborne botulism, a food poisoning, which has been traditionally the most 
prevalent form of botulism and is therefore called “classical” botulism. It was also the first 
form of the disease described in 1817 by Steinbruch and Kerner (Erbguth, 2004). The 
name botulism relates to the first food item observed to induce the disease, spoiled blood 
sausage (from the Latin word botulus, meaning “sausage”). However, BoNT formation in 
foods can precede signs of spoilage, thus seemingly unspoiled food items may indeed 
contain high levels of BoNT (Lawlor et al., 2000; Kasai et al., 2005; Lindström et al., 
2006). Foodborne botulism is the most prevalent form of botulism in Europe, and 
expected to be underreported (Therre, 1999; Peck et al., 2011; Carter & Peck, 2015). 
Cases are often linked to the consumption of insufficiently processed, canned or bottled, 
often home-preserved foods, (Group I C. botulinum), traditionally fermented or smoked 
meat or fish products (primarily Group II), or inadequately stored food items (temperature 
abused, beyond due-date) (Group I and II) (Lindström et al., 2006; Peck, 2009; Cowden, 
2011; Carter & Peck, 2015). Modern food processing methods like mild pasteurization 
treatments, anaerobic packaging, extended shelf lives and chilled storage have led to an 
increase in Group II C. botulinum caused outbreaks related to commercial products 
(Lindström et al., 2006; Peck, 2006). 
 
Infant botulism. The premature intestines of children less than one year of age can be 
colonized with C. botulinum after ingestion of clostridial spores due to lack of competitive 
intestinal microbiota. Synthesis of BoNT in vivo, followed by absorption into the 
bloodstream, can lead to infant botulism (Arnon et al., 1981). Typical clinical signs are 
poor feeding and lethargy, constipation, hypotonia, dilated pupils, and absent reflexes in 
infants. Group I BoNT/A or B producing strains are usually involved, however, cases 
caused by BoNT/F or E forming C. botulinum as well as BoNT/F forming C. baratii and 
BoNT/E forming C. butyricum have also been reported (Koepke et al., 2008). The disease 
has been associated with sudden infant death syndrome. Spores of C. botulinum present in 
honey or dust have been identified as the primary source for the infection of infants, but 
also aquatic reptiles in the household have been linked to the disease (Arnon et al., 1981; 
Nevas et al., 2002; Derman et al., 2014; Shelley et al., 2015). After suffering from infant 
botulism, clinically healthy children can carry and excrete vegetative cells and spores of 
C. botulinum for several months and need therefore to be considered a potential source of 
infection for caretakers and other children (Derman et al., 2014). The infant form is the 
most prevalent form of botulism to date in the United States, however, it is believed to be 
strongly underreported (Koepke et al., 2008). A human-derived immunoglobulin was 
developed for the treatment of infant botulism to reduce adverse effects caused by the 
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administration of antitoxin produced in animals and has proven to be beneficial for 
recovery of young patients (Arnon et al., 2006). 
 
Wound botulism. Contamination of deep wounds with spores of C. botulinum can result 
in vegetative growth and in situ BoNT synthesis in the anaerobic wound environment. 
Entrance of the toxin into the human bloodstream can lead to systemic intoxication. This 
rare form of botulism has so far been related mainly to environmental contamination of 
traumatic injuries (Werner et al., 2000; Sobel, 2005; Schroeter et al., 2009). It has recently 
become an increasing problem in drug abusers, especially those injecting paravenously, 
due to contaminated heroine and needles. The clinical appearance resembles foodborne 
botulism, beside the lack of gastrointestinal symptoms. In addition to the conventional 
botulism treatment, antimicrobial therapy is indicated and the infected wound needs to be 
cleaned (Sobel, 2005).  
 
 
2.2. Relevance of C. botulinum for the food industry  
 
The costs of treating foodborne botulism have been estimated to be £22,000 (today worth 
about €52,000) per patient in an outbreak linked to contaminated hazelnut yoghurt 
produced in the United Kingdom in 1989 (Roberts, 2000). Other outbreak-related costs 
arise from outbreak investigations (estimated £6,000 in the above-mentioned case), recall 
of the product, loss of consumer trust, and possible legal charges of affected people. In the 
U.S., there are lawyer’s offices specialized in representing victims of foodborne illnesses, 
including botulism (e.g. www.botulismblog.com). An outbreak in the U.S. from 1978 
involving 34 people was quoted to have created costs of more than $5,000,000; in 1997 
estimations were made of costs up to $30 million per human foodborne botulism case 
caused by a commercial product (Mann et al., 1983; Setlow & Johnson, 1997). Even 
though outbreaks related to commercial foods are relatively rare, they cause severe 
disease, might affect a large number of people, and have a dramatic economic impact on 
the health care system as well as the company involved, potentially leading to bankruptcy 
of the business (Mann et al., 1983; Setlow & Johnson, 1997; Sobel et al., 2004; Lindström 
& Korkeala, 2006; Carter & Peck, 2015). 
Since C. botulinum spores are ubiquitous in the environment, contamination of raw 
materials in food production can never be entirely excluded, even when applying good 
hygiene practice to keep contamination levels low. Therefore effective measures to control 
and prevent formation of toxigenic culture in food products are indispensable. Botulism 
outbreaks related to commercial products can often be linked to process failure, post-
process contamination, use of contaminated ingredients, and temperature abuse, as well as 
other improper food handling practices by the consumer (Sobel et al., 2004; Lindström & 
Korkeala, 2006; Lindström et al., 2006). 
 The differences between Group I and Group II C. botulinum regarding physiology and 
especially spore resistance have a great impact on their risk profiles (Lindström et al., 
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2006; Peck, 2009; Carter & Peck, 2015). This has to be addressed by the food industry. 
Group I strains are mesophilic and not able to grow under 10 °C, therefore outgrowth and 
BoNT synthesis of these strains can be easily controlled by chilled storage. However, as 
their highly-resistant spores might survive even strong heat treatment, they pose a risk in 
products preserved by canning or bottling, which are intended to be stored for extended 
time at room temperature under anaerobic conditions. Group I C. botulinum is commonly 
related to home-canned non-commercial products, since introduction of harsh heat 
treatment during the industrial canning process (the so-called botulinum cook, 3-6 min at 
121 °C) has greatly reduced the number of cases related to commercial products (Stumbo 
et al., 1975; Peck, 2009; Setlow & Johnson, 2013; Dahlsten et al., 2015). However, 
insufficient heat treatment and post processing contamination have resulted in several 
outbreaks linked to industrial products, some of them leading to human death (Sobel et al., 
2004; Peck, 2009; Jalava et al., 2011). A major problem that remains is improper food-
handling practice, resulting in temperature abuse on a consumer as well as retail level, and 
insufficient heating before consumption. Room temperature storage of non-acidified 
products, which did not undergo heat treatment sufficient to kill heat resistant spores, 
allows growth and BoNT production of C. botulinum Group I. Some of the products 
involved in outbreaks in the past years were found to be labelled insufficiently with regard 
to storage temperature (Sobel et al., 2004).   
In recent years, the availability of refrigerated processed foods of extended durability 
(REPFED) has grown to meet consumers’ increasing demand for convenient, mildly-
treated food with high gustatory quality (Lindström et al., 2006; Lindström et al., 2006; 
Peck, 2006; Peck et al., 2008). These products contain low levels of salt and other 
preservatives and are only minimally heat treated, but nevertheless have long shelf lives. 
Thus, the hurdles commonly used to ensure safety of food products, like heat treatment, 
increased osmolarity, or low water activity, low pH, and preservatives, are kept low and 
might be insufficient. Therefore, the control of microbial growth and BoNT formation in 
these products relies to a substantial degree on storage at chilled temperatures (Leistner, 
2000; Lindström et al., 2006; Peck, 2006). This measure is sufficient to prevent risk of 
Group I C. botulinum. However, being psychrotrophic, Group II is capable of growth and 
BoNT formation at chill temperature, especially during extended shelf life achieved by 
modified atmosphere packaging (Eklund et al., 1967; Lindström et al., 2006). Further, 
competitive microbial population in the product is inhibited by lack of oxygen or killed by 
the applied mild heat treatment, which in turn might be survived by clostridial spores 
(Hyytia-Trees et al., 2000). In addition, many REPFEDs are intended not to be heated 
prior consumption. These factors increase the risk of foodborne botulism caused by 
REPFEDs and also explain the increase of botulism cases associated to commercial 
products related to Group II strains paralleling the emergence of REPFEDs (Sobel et al., 
2004; Lindström et al., 2006; Peck, 2006; Peck, 2009). Many of these cases were linked to 
the consumption of raw, cured, or smoked fish and sea food (Korkeala et al., 1998; 
Lindström et al., 2006; King et al., 2009). These products are of special concern as high 
levels of Group II C. botulinum spores are commonly reported in their raw materials 
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(Hielm et al., 1998b; Hyytiä et al., 1998). Many studies have been performed and 
predictive models were developed to estimate the effect of heat treatment and food 
materials and ingredients on growth from Group II spores during chilled storage in 
REPFEDs, in order to help to control the risk of foodborne botulism by Group II C. 
botulinum (Hyytia-Trees et al., 2000; Lindström et al., 2006; Peck, 2006; Peck et al., 
2008; Ihekwaba et al., 2016; Ihekwaba et al., 2016).  
Even though the hazards regarding BoNT production in commercial food products have 
been recognized and risk management strategies have been developed and implemented 
for decades, the control of C. botulinum remains an enormous challenge for the food 
industry (Lindström et al., 2006; Ihekwaba et al., 2016). 
 
 
2.3. Heat stress response in the Gram-positive model organism 
Bacillus subtilis 
 
Being constantly exposed to changing and challenging environments, bacterial survival 
depends substantially on the ability to immediately respond to growth-limiting stresses. 
The impact of temperature, one of the most important environmental factors affecting all 
living cells, on the Gram-positive model organism B. subtilis, but also on human 
pathogens like Listeria monocytogenes, C. difficile, and Staphylococcus aureus, has been 
studied intensively in the past years (Hecker et al., 1996; Helmann et al., 2001; 
Schumann, 2003; Anderson et al., 2006; van der Veen et al., 2007; Ternan et al., 2012). 
The response to sudden temperature increase leads to a shift in the cellular behavior on 
both a transcriptional and a translational level, the so-called ”heat shock response”, in 
order to enhance survival (Schumann, 2003). In pathogenic bacteria modulation of 
virulence factors has been observed in response to heat stress (Anderson et al., 2006; van 
der Veen et al., 2007; Emerson et al., 2008). Studies on the heat shock response of 
bacteria are of particular value as it resembles the general stress response to a large degree, 
which is utilized to resist other environmental challenges like salt, pH, or ethanol stress, 
and therefore presents a model for it (Hecker et al., 1996). Especially foodborne pathogens 
encounter a number of different stresses during processing, storage, but also in the human 
host, one of them is heat stress. 
An increase of only a few degrees in environmental temperature initiates a rapid heat 
shock response in the bacterial cell. The assumed reason for this seemingly low threshold 
is the significant temperature sensitivity of protein conformation and stability (Richter 
et al., 2010). At elevated temperature, a proportion of the intracellular proteins will be 
misfolded, unfolded, even denatured, or aggregated, and overall cellular function will be 
impaired (Baldwin, 1986; Dobson, 2003). But the damaging effect of heat is not limited to 
proteins. Other cellular components like rRNA, ribosomes, DNA, and the cell membrane 
will also be affected by heat (Lim & Gross, 2011). It has been commonly accepted that the 
increasing amount of misfolded or unfolded protein in the cytosol is the signal that triggers 
the heat shock response in bacteria, since one main aim of the heat shock response is to 
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preserve protein homeostasis (Lim & Gross, 2011). But recently it has been discovered 
that one major regulator of the bacterial heat shock response, the transcriptional repressor 
CtsR, binds in a temperature-dependent manner to DNA and acts itself as a thermosensor 
(Elsholz et al., 2010). In B. subtilis, genes coding heat shock response proteins are 
grouped according to their mode of regulation. Its heat shock response is dominated by 
three major regulons: the SigB, HrcA, and CtsR controlled regulons (Hecker et al., 1996; 
Schumann, 2003). 
The largest group of proteins induced immediately after heat shock in B. subtilis are 
considered to be general stress proteins; they are also activated by other stresses like salt, 
ethanol, desiccation, acidity, or antibiotics, and under energy stress due to starvation for 
oxygen, glucose, or phosphate (Hecker et al., 1996; Schumann, 2003; Hecker et al., 2007). 
The more than 150 genes coding these proteins, the Class II heat shock genes (HSG), are 
under positive control of an alternative sigma factor, SigB (Helmann et al., 2001; Price 
et al., 2001; Price, 2011). The SigB regulon is rapidly activated after heat shock in 
B. subtilis, but the expression decreases from 10 min after a temperature up-shift 
(Schumann, 2003). A number of the genes code for proteins with clear protective 
functions: several are related to reduction of oxidative stress, DNA binding and DNA 
protection, transporters for compatible solutes, antibiotic resistance, cold stress resistance, 
and cell envelope functions (Hecker et al., 2007; Price, 2011). However, the SigB regulon 
encompasses predominantly genes with so far unknown functions. The regulon plays a 
crucial role with regard to virulence in L. monocytogenes and S. aureus (Anderson et al., 
2006; van der Veen et al., 2007). It is believed that no sigB homologs are present in any 
anaerobic bacteria (Hecker et al., 2007). Several genes originally annotated as sigB in 
clostridial strains (Sebaihia et al., 2006; Fonknechten et al., 2010; Bao et al., 2011) were 
later re-annotated as RNA polymerase sigma-70 factor coding genes. For C. botulinum, a 
sigB homolog has never been described, nevertheless, homologs to some B. subtilis 
Class II HSGs are present in its genome (Sebaihia et al., 2007).  
The two other major classes of B. subtilis HSGs, Class I and Class III, code for proteins 
primarily addressing the challenge of protein misfolding, denaturation, and aggregation in 
the heat-stressed bacterial cell. Both classes of HSGs are present in C. botulinum. They 
encode a protein quality control system of molecular chaperons and proteases that is 
involved in protein folding, refolding, control, and degradation. Both classes are under 
negative transcriptional regulation and de-repressed by non-native proteins.  
The Class I HSGs code for molecular chaperones. These proteins assist misfolded, as 
well as newly synthesized unfolded proteins to reach their native state, and therefore 
promote proper protein assembly (Langer et al., 1992a; Schröder et al., 1993; Hartl & 
Hayer-Hartl, 2002). Class I HSGs consist of two operons, the dnaK and the groELS 
operon, which are universally conserved through all kingdoms. In Gram-positive bacteria 
like B. subtilis, they are under the control of the transcriptional repressor HrcA (Schulz & 
Schumann, 1996; Schulz & Schumann, 1996; Schumann, 2003). Their expression 
involves a SigA-dependent promoter.  
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Non-native proteins expose a high ratio of hydrophobic amino acid residues on their 
surface. The molecular chaperonin GroEL forms a cylinder of 14 subunits, which 
complexes with its co-chaperonin GroES (Langer et al., 1992b; Hayer-Hartl et al., 2015). 
This cylinder provides an isolated, highly hydrophilic environment triggering protein 
folding. It binds unfolded protein and encapsulates it, supporting burying of hydrophobic 
residues to the inside of the protein and thus mediating correct folding (Martin et al., 
1993). The binding affinity of proteins to the GroEL chaperonin is ATP controlled. In 
B. subtilis GroEL plays a major role in response to various stresses, but also in de novo 
protein folding (Hartl, 1996; Hartl & Hayer-Hartl, 2002; Dobson, 2003). The DnaK 
chaperone, encoded in the second HrcA regulated operon, also binds and stabilizes 
unfolded regions of proteins, keeping them separated from unspecific interaction partners, 
thus reducing undesired irreversible protein aggregation and misfolding (Langer et al., 
1992a). The molecular chaperone DnaJ is also dnaK-operon encoded and is thought to 
stabilize the complex of non-native protein and DnaK. The unfolded protein is then 
transferred with the help of GrpE, also dnaK-operon encoded, to the GroELS complex for 
refolding (Langer et al., 1992a). In the Gram-negatives E. coli and Thermus thermophiles, 
it has been shown that DnaK is further able to repair heat-induced protein damage and 
aggregation in cooperation with the proteins GrpE and DnaJ, and the Class III HSG-
encoded ClpB protease (Schröder et al., 1993; Motohashi et al., 1999). Class I HSGs are 
under negative control of HrcA. This transcriptional repressor needs to be continuously 
refolded by the GroELS complex to remain active. High temperature stress leads to an 
increase of unfolded proteins in the cytosol, which will compete with HrcA for binding to 
GroELS and eventually titrate it away (Mogk et al., 1998). Inactivation of HrcA then will 
lead to de-repression of Class I HSGs. 
Irreversibly-damaged proteins need to be removed from the bacterial cell, even though 
refolding of non-native proteins induced by heat stress is the preferred mechanism by any 
organism as it is less energy consuming. Proteolytic enzymes contribute to the heat shock 
response by clearing up these denatured proteins via degradation. The Class III HSGs of 
B. subtilis are organized into three operons and code for ATP-dependent Clp proteases; 
clpP for the proteolytic, clpC and clpE for the ATPase subunits (Schumann, 2003). ClpC 
and ClpP have also been associated to the stationary-phase regulatory network and the 
development of competence in B. subtilis (Msadek et al., 1994; Msadek et al., 1998). Clp 
proteases are considered to be the major protein quality control system for the cell and are 
under negative regulation of CtsR (Derré et al., 1999; Schumann, 2003). This proteolytic 
system is strictly regulated: CtsR is inactivated by the kinase McsB, which again is 
inactive when bound to the ClpCP complex. However, this complex has a higher affinity 
to unfolded proteins, which if present in high concentration leads to release and activation 
of McsB after heat shock. This will result in inactivation of the transcriptional repressor 
CtsR and finally to activation of Class III HSGs (Kirstein et al., 2005). CtsR itself binds to 
DNA in a temperature-dependent manner, with reduced binding at high temperature, and 
has been considered to be a thermosensor (Elsholz et al., 2010). 
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The exposure to sublethal heat stress has been shown to have a protective effect on 
subsequent heat treatment at lethal temperatures in B. subtilis (Volker et al., 1992). 
Activation of the heat shock response induced a preadaptation of the bacterial cell, 
increasing its thermotolerance and protecting it shortly after from otherwise lethal 
temperatures. In addition, this mild heat treatment caused so-called cross-protection, 
permitting the bacteria to survive otherwise toxic NaCl concentrations (Volker et al., 
1992). Mild NaCl stress also enhanced thermotolerance, although to a lesser degree. 
Stress-induced acquired thermotolerance and cross-protection have been reported for other 
foodborne pathogens such as E. coli, L. monocytogenes, and Salmonella and have been 
acknowledged as a risk with regards to food safety, especially when applying hurdle 
technology (reviewed by Wesche et al.) (Lou & Yousef, 1996; Juneja et al., 1998; Wesche 
et al., 2009). 
 
 
2.4. Molecular mechanisms of stress response in C. botulinum 
 
2.4.1. Heat stress response 
 
One of the first studies investigating the heat shock response in C. botulinum observed an 
overexpression of nine heat shock proteins when mid-exponentially growing batch culture 
of the type A strain Hall was exposed to heat shock from 37 °C to 45 °C (Shukla & Singh, 
1999).  The overexpression of these proteins was detected from 15 min after heat shock 
onwards and reached a maximum after 30 min. The bacterial culture further showed a 
change in growth behavior: 4 h post heat shock a lower cell density at 45 °C compared to 
37 °C was recorded, which then dramatically dropped after 10 h. One of the overexpressed 
proteins was described as a DnaJ-like chaperone; the first heat shock protein to be reported 
in C. botulinum (Shukla & Singh, 1999). Another protein found to be overexpressed was 
later identified to be the ANTP HA33 (Shukla & Singh, 1999; Shukla & Singh, 2009). 
The heat shock chaperonin complex GroELS has been described in a C. botulinum type D 
strain after it was detected in culture supernatant during toxin production under growth 
conditions considered not stressful (Sagane et al., 2003). The toxigenic type D strain 
showed higher GroELS expression compared to a non-toxic strain, which prompted 
speculation for a possible role of the chaperonin complex in toxin production or 
translocation over the cell membrane, which has not yet been confirmed (Sagane et al., 
2003).  
A recent transcriptomic analysis of C. botulinum ATCC 3502 under heat stress at 45 °C 
for 15 min revealed overexpression of the Class I HSG operons dnaK and groESL. In 
contrast, Class III HSGs were found to be unaffected in C. botulinum (Liang et al., 2013). 
The exposure of the mid-exponential growing culture to heat shock further led to reduced 
expression of genes related to aminoacyl-tRNA synthetase, ribosomal structure and cell 
division proteins, confirming a growth arrest after heat shock detected earlier (Shukla & 
Singh, 1999; Liang et al., 2013). Other genes affected by heat stress in mid-exponential 
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cells were associated to transcriptional regulation, energy production and conversion, 
transport, cell wall and membrane biogenesis, and flagella biosynthesis. However, their 
contribution to the C. botulinum heat shock response remains to be characterized. 
Interestingly, no significant changes in the expression levels of any NTC genes or genes 
related to sporulation could be detected (Liang et al., 2013). Only mild up-regulation was 
observed for ha17 and for ha33, which codes for an ANTP considered by Shukla et al. as 
a heat shock protein (Shukla & Singh, 2009). In addition, comparison of C. botulinum 
culture growing at 37 °C with culture growing at 44 °C showed no significant differences 
in NTC gene expression (Couesnon et al., 2006). 
 
2.4.2. Cold stress response  
 
The main effects of low temperature on cellular components are reduced membrane 
fluidity due to solidification of fatty acids, impairment of the transcriptional and 
translational machinery due to increased stability of secondary structures in nucleic acids, 
especially RNA, changes in protein folding and enzyme efficiency, and reduced ribosome 
function (Weber & Marahiel, 2003; Phadtare, 2004; Lim & Gross, 2011). Exposure to a 
sudden drop in environmental temperature leads to complex changes in the bacterial 
physiology to overcome these problems, the so-called cold shock response. In contrast to 
the bacterial heat shock response, the cold shock response appears to be regulated in a 
more heterogeneous manner and seems to employ a wider range of molecular systems 
(Weber & Marahiel, 2003). Given the importance of the foodborne pathogen C. botulinum 
with regard to growth and BoNT formation in food during storage at chill temperature, a 
number of studies have been performed to elucidate the molecular mechanisms of cold 
tolerance this bacterium utilizes (Söderholm et al., 2011; Lindström et al., 2012; Dahlsten 
et al., 2014; Dahlsten et al., 2014; Mascher et al., 2014; Söderholm et al., 2015).  
Sequencing of the genome of the Group I C. botulinum strain ATCC 3502 revealed the 
presence of three genes annotated as cold shock genes cspA – cspC, containing a nucleic 
acid binding cold shock domain (Sebaihia et al., 2007). Of these, cspB has been shown to 
encode the major cold shock protein in the strain: its insertional inactivation led to the 
strongest growth impairment at low temperature (Söderholm et al., 2011). In contrast, 
cspA inactivation led to no cold sensitive phenotype. However, the transcription of all 
three cold shock protein-coding genes was up-regulated 30 min after cold shock 
(Söderholm et al., 2011). Further studies on Group I C. botulinum cold shock genes 
revealed the importance of cspB and cspC for other environmental stresses and motility 
(Derman et al., 2015). Interestingly, cold shock protein-coding genes, even though thought 
to be universally conserved, appear to be absent in Group II C. botulinum type E strains 
(Söderholm et al., 2013). It is unknown how their role in cold tolerance is compensated in 
these strains. 
A recent study profiling the gene expression of the Group I C. botulinum strain 
ATCC 3502 after cold shock from 37 °C to 15 °C using DNA microarrays revealed an 
extensive remodeling of the bacterial metabolism after long term exposure to cold, 
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whereas the transcription of only 28 genes was affected 1 h after cold shock (Dahlsten 
et al., 2014). The cold shock led to a slight up-regulation of ha genes, but left the rest of 
the NTC unaffected. Among the genes that were early up-regulated after cold shock was 
csdA (cbo2802), encoding a DEAD/DEAH box family RNA helicase. These types of 
helicases have been shown to be essential for B. subtilis. It has been proposed that they 
work in cooperation with cold shock proteins as chaperones to enhance the translation 
initiation of mRNA, which has increased stability at low temperature that is hampering 
ribosomal function (Hunger et al., 2006). For C. botulinum, the csdA gene has been 
observed to be important for growth at low temperature, as its inactivation led to impaired 
growth and motility at 20 °C compared to 37 °C and increased low temperature growth 
limits (Söderholm et al., 2015). The above-mentioned expression profiling study further 
observed a significant increase in the transcription levels of genes related to up-take of 
compatible solutes, which might function as cryo- and osmo-protectants in the bacterial 
cell (Dahlsten et al., 2014). Prolonged exposure of the Group I C. botulinum strain 
ATCC 3502 also led to changes in the expression of genes related to fatty acid 
metabolism, probably leading to changes in the cell membrane composition to reduce its 
solidification, which is a problem commonly encountered during bacterial cold stress 
(Dahlsten et al., 2014). Remodeling of the fatty acid composition in response to reduced 
growth temperature has been observed in Group II C. botulinum as well (Evans et al., 
1998). Other genes identified as cold stress affected in the microarray study could be 
related to, at least, redox stress, SOS response, changes in amino acid metabolism, and 
transcriptional regulation (Dahlsten et al., 2014). However, their impact on cold tolerance 
in C. botulinum needs to be further characterized. 
Not much is known about the regulatory network controlling the cold stress response of 
C. botulinum. Recently, TCSs sensing the bacterial environment have been shown to play 
a role in group I as well as Group II C. botulinum cold tolerance: Genes coding the  for 
TCS CBO0366/CBO0365 and CBO2306/CBO2307 in the Group I strain ATCC 3502 
(Lindström et al., 2012; Derman et al., 2013) and CLO3403/CLO3404 in the Group II 
strain E1 Beluga (Mascher et al., 2014) were found to be up-regulated upon temperature 
down-shift and their inactivation led to a cold-sensitive phenotype with reduced growth 
performance at low, but not at optimal, temperature. Interestingly, an additional study 
further characterizing the CBO0365 response regulator revealed that the expression of its 
regulon was almost unaffected by temperature (Dahlsten et al., 2014). However, the 
authors demonstrated that inactivation of a number of genes of this CBO0365 regulon led 
to deteriorated growth at suboptimal temperature. They therefore suggested that 
mechanisms controlled by the TCS CBO0366/CBO0365 related to the solvent formation 
pathway, components of the arsenic resistance machinery and phosphate uptake contribute 
to the cold stress response of Group I C. botulinum strain ATCC 3502 (Dahlsten et al., 
2014). None of these had previously been associated to temperature stress tolerance. 
Another regulatory protein, the sporulation sigma factor SigK, has been shown to play 
a role in cold tolerance of Group I C. botulinum ATCC 3502 as well (Dahlsten et al., 
2013). The transcription of the SigK coding gene increased significantly after cold shock 
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and its inactivation led to reduced growth at low temperature. The authors speculated that 
SigK might to some degree substitute the B. subtilis general stress sigma factor SigB, 
which C. botulinum is lacking (Sebaihia et al., 2007; Dahlsten et al., 2013). 
 
2.4.3. Other stresses  
 
Even though temperature-, especially cold-stress, is the most thoroughly studied 
environmental stress in C. botulinum, other stresses are also significant for this foodborne 
pathogen. In the environment, during food processing and storage, and also in the animal 
host, C. botulinum needs to resist changes not only in temperature but also in pH, 
osmolarity, water activity, nutrient availability, oxygen levels, and preservatives 
(Lindström et al., 2006; Peck, 2009; Dahlsten et al., 2015).  
Several mechanisms associated to the cold shock response in Group I C. botulinum 
have been recently linked to the response to other stresses in the bacterium as well. The 
sporulation sigma factor SigK coding gene was found to be up-regulated after exposure to 
high NaCl concentration and its inactivation led to increase of lag time when grown at 
high salinity, whereas no effect on tolerance to acid stress was observed (Dahlsten et al., 
2013). An additional role for SigK in response and adaptation to hyperosmotic conditions 
was thus suggested. It has further been shown that the cold shock protein coding genes 
cspB and cspC are of importance for the response of C. botulinum to NaCl, low pH and 
ethanol stress (Derman et al., 2015). Of these genes, the major cold shock gene cspB was 
again identified to have the greatest impact on the stress tolerance as its inactivation led to 
more deteriorated growth in the tested conditions.  It was therefore proposed to have a 
universal role in stress response. Even though the inhibiting effects of many other 
environmental factors on the vegetative growth of C. botulinum have been thoroughly 
studied to improve food safety, their underlying molecular mechanisms have not yet been 
characterized. 
The evident participation of cold tolerance mechanisms in the response to other stresses 
emphasizes that cross-protection and probably induced stress tolerance by sublethal stress 
most likely exist in C. botulinum. When using hurdle technology in food preservation to 
prevent growth and BoNT formation of C. botulinum, which is a common trend in the 
modern food industry, the applied mild treatments could hence lead to unexpectedly 
increased tolerance of subsequent preservation methods in minimally processed foods. 
Therefore, the effects and mechanisms of induced stress tolerance and cross-protection in 
C. botulinum require more thorough characterization and should be taken into 
consideration when designing measures to ensure microbial safety of foods with regard to 
C. botulinum. 
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3. AIMS OF THE STUDY 
 
 
The objectives of this study were to explore the strain variation of Group I and Group II 
C. botulinum with regard to growth at stressful temperatures and to investigate 
mechanisms of heat shock and heat stress response of Group I C. botulinum. 
 
The specific aims were:  
 
1. To investigate the minimum and maximum growth temperatures of  23 Group I and 24 
Group II C. botulinum strains and their growth rates at a low, optimal, and high 
temperature to explore strain variation (I, II), 
 
2. To study the biological functions of the Class I heat shock genes hrcA and dnaK in the 
stress response of Group I C. botulinum strain ATCC 3502 (III), and 
 
3. To obtain whole genome gene expression profiles for the Group I C. botulinum strain 
ATCC 3502 grown in continuous culture during heat shock, during and after 
adaptation to high temperature (IV). 
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4. MATERIALS AND METHODS 
 
 
4.1. Strains and plasmids 
 
Twenty-three Group I strains and twenty-four Group II strains were used to study strain 
variation with regard to growth temperature within the groups and were selected to 
represent strains with a wide genetic background and of different origins (I, II) (Table 2). 
The Group I strains included five strains of serotype A, two of type AB (one Ab and one 
A[B]), 14 type B, and two of type F. The Group II strains consisted of three serotype B, 16 
type E, and five type F strains.  
The Group I C. botulinum strain ATCC 3502 (III, IV) as well as mutant strains 
originating from this strain carrying a single insertional mutation in hrcA (cbo2961) or 
dnaK (cbo2959) (III), were used to examine mechanisms of high temperature stress 
tolerance. Cloning, donor, and mutant strains and plasmids are listed in Table 3. 
 
Table 2.  Clostridium botulinum wild type strains used in this study. 
 
 Type Straina Origin Sourceb 
Group I C. botulinum   
 A ATCC 3502 Unknown ATCC  
  RS-3A Pacific Red Snapper, USA, 
Pacific coast 
S. Lindroth, UCDAVIS  
  ATCC 25763 Type strain  ATCC  
  DA 100/1 S Danish honey DFHEH 
  96 A Unknown T. Roberts  
 AB CDC 588  Botulism outbreak, USA IFR  
  NCTC 2916 Corn CAMR  
 B P 1/3  Canned deer meat, Finland DFHEH 
  M 1/3 Soil, Finland DFHEH 
  BL 150 Fish Unilever  
  BL 81/25 Asparagus LFRA  
  NCTC 3815 Cheese Unilever  
  DA 58/1 Danish honey DFHEH 
  M 316/5 Soil, Finland DFHEH 
  CDC 7827 Human stool CDC  
  M 193/15  Soil, Finland DFHEH 
  P 120/6 Household dust, infant botulism 
case, Finland  
DFHEH 
  ATCC 17841 Unknown ATCC  
  126 B Unknown Institut Pasteur 
  525 S/8 Honey-comb pollen DFHEH 
  KS 44/10 Honey-comb pollen DFHEH 
 F ATCC 35415 Liver paste P. McClure, Unilever  
  ATCC 25764 Crab ATCC  
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Table 2.          Continued 
     
 Type Straina Origin Sourceb 
Group II C. botulinum 
 B Eklund 17  
(ATCC 25765) 
Marine sediment ATCC 
  BL 93/6 (CDC 5900) Human IFR 
  BL 90/4 (Prevot 59) Unknown ATCC 
 E K3 Rainbow trout surface DFHEH 
  K8 Rainbow trout intestines DFHEH 
  K35 Vendace DFHEH 
  K36 Rainbow trout DFHEH 
  K42 Rainbow trout intestines DFHEH 
  K44 Rainbow trout intestines DFHEH 
  K51 Rainbow trout surface DFHEH 
  K101 Chub surface DFHEH 
  K117 White fish DFHEH 
  K119 Rainbow trout intestines DFHEH 
  K125 Rainbow trout roe DFHEH 
  BL 93/8 (CDC 8073) Human IFR 
  31-2570 Unknown DFHEH 
  BL 81/26 (Beluga) Beluga flipper IFR 
  S16 Fishpond sediment DFHEH 
  CB11/1-1 Whitefish roe DFHEH 
 F 202 (ATCC 23387) Marine sediment ATCC 
  BL 86/32 (Colworth 
47) 
Unknown IFR 
  BL 86/33 (Colworth 
187) 
Unknown IFR 
  BL 86/34 (Colworth 
195) 
Unknown IFR 
  610B8-6 Salmon S. Lindroth, UCDAVIS 
     
a multiple names of strains in brackets 
bATCC: American Type Culture Collection, Manassas, Va., USA; DFHEH: Department of Food Hygiene and 
Environmental Health, University of Helsinki, Finland; UCDAVIS: University of California, Davis, USA; IFR: 
Culture collection of the Institute of Food Research, Norwich, UK; CAMR: Centre for Applied Microbiology 
and Research, Salisbury, UK; LFRA: Leatherhead Food Research Association, Surrey, UK; CDC: Centers for 
Disease Control and Prevention, USA 
 
 
 
4.2. Culture preparation (I-IV) 
 
All C. botulinum strains used in the studies, with exception of the mutant strains (III), 
were cultured from spore stocks. These have been prepared from strains of the collection 
of the Department of Food Hygiene and Environmental Health, University of Helsinki, 
Finland, after incubation for 2-3 days on blood agar plates (5% bovine blood, 10 g/liter 
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agar), followed by re-inoculation of single colonies into 50 ml fresh tryptone-peptone-
glucose-yeast extract (TPGY) broth (50 g/liter tryptone, 5 g/liter peptone, 20 g/liter yeast 
extract [Difco, BD Diagnostic Systems, Sparks, MD], 4 g/liter glucose [VWR 
International, Leuven, Belgium], 1 g/liter sodium thioglycolate [Merck, Darmstadt, 
Germany]) and incubation for 7 days. After the BoNT serotype of the cultures was 
confirmed by multiplex PCR (Lindström et al., 2001), the cells were heat treated for 15 
min at 85 °C in a water bath to kill remaining vegetative cells; the spores were washed and 
stored in sterile water at 4 °C. The C. botulinum mutant strains (III) were cultured from 
frozen stocks stored in TPGY broth supplemented with 20% glycerol (Sigma-Aldrich, 
Steinheim, Germany).  
Routinely, the strains were initially grown from spore or frozen stocks for 24 h in 10 ml 
deoxygenated TPGY broth (I, II) or buffered TPGY broth (6.25 g/liter NaH2PO4, 5.45 
g/liter KH2PO4 [VWR International], pH 7) (III, IV) at 30 °C (II) or 37 °C (I, III, and IV), 
here referred to as the first overnight culture. A volume of 100 μl of the first overnight 
cultures was re-inoculated into in 10 ml deoxygenated TPGY broth (I, II) or buffered 
TPGY broth (III) and grown anaerobically for 16 h at 30 °C (II) or 37 °C (I, III), here 
referred to as the second overnight culture.   
All work handling viable C. botulinum cells was performed and all cultures were grown 
under anaerobic conditions in an anaerobic cabinet (MG1000 Anaerobic Work Station; 
Don Whitley Scientific Ltd., Shipley, United Kingdom) with an internal atmosphere of 
85% N2, 10% CO2, and 5% H2 (study I-IV) or in a Braun Biostat B fermenter (B. Braun, 
Germany) flushed with N2 (study IV). All culture media were deoxygenated by boiling for 
15 min (broth) or anaerobic storage for 48 h (agar plates).  
 
 
4.3. Minimum and maximum growth temperatures (I-III) 
 
The GradiplateW10 temperature gradient incubator (BCDE Group, Helsinki, Finland) 
placed in an anaerobic workstation (MK III) was used to determine the minimum and 
maximum temperatures permitting growth of the 23 Group I (I) and the 24 Group II (II) 
strains and the maximum growth boundaries of the hrcA and dnaK mutant as well as 
parent C. botulinum strains (III). This incubator creates a uniform temperature gradient 
along the vertically-incubated agar plate. The temperature gradient g (in °C/mm) in the 
plate can be derived from the temperatures measured by two calibrated temperature 
sensors at a distance of 24 mm (Tlow) and 74 mm (Thigh) from the bottom edge of the agar 
plate using the formula g = (Thigh-Tlow)/50 mm (in °C/mm). This allows calculation of the 
incubation temperature Tinc (°C) at any point in the plate by measurement of its distance d 
(in mm) to Tlow using the formula: Tinc = Tlow + d x g.  
A volume of 100 μl of the second overnight culture of the strains to be studied was 
inoculated into 10 ml deoxygenated TPGY and grown at 37 °C (I, III) or 30 °C (II) to 
reach the exponential growth phase, corresponding to an OD600 of 0.8 to 1.2 ODU (I, III) 
or 0.6 to 0.9 ODU (II). Each logarithmically-growing strain was then diluted 1:100 in 
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peptone water, and 25 μl of this dilution was inoculated onto anaerobic TPGY agar plates 
(25 g of agar per liter) using the droplet-run technique in a longitudinal direction 
(Korkeala et al., 1990). To determine their minimum growth temperature (Tmin), the 
strains were incubated at a temperature range from 12 °C to 18 °C for 35 d (I) or from 
3 °C to 9 °C for 28 d (II). To study their maximum growth temperature (Tmax), the strains 
were incubated at a temperature range from 40 °C to 48.5 °C (I), 33 °C to 42 °C (II), or 
42 °C to 49 °C (III) for 48 h. 
At the end of incubation, the growth boundary, determined as margin at which dense 
growth of each strain stopped, was observed optically using a stereo microscope or with 
the bare eye, and its distance to Tlow measured. The Tinc at this growth boundary was then 
obtained using the above-mentioned formulas. The Tmin and Tmax of each strain were 
determined as the mean of Tinc of three (I: Tmax, II, III) or five (I: Tmin) independent 
experiments.   
 
 
4.4. Growth characteristic experiments (I-III) 
 
The C. botulinum strains were incubated in a Bioscreen C Microbiology Reader (Oy 
Growth Curves AB Ltd., Helsinki, Finland), that was placed in an anaerobic cabinet (MK 
III, Don Whitley Scientific Ltd.), to examine the growth characteristics of the 
23 Group I (I), 24 Group II (II), and the mutant as well as parent strains (III). The 
Bioscreen C Microbiology Reader controls the incubation temperature of the bacterial 
culture, shakes it, and automatically measures and reports its optical density at the 
wavelength of 600 nm (OD600) in optical density units (ODU) in intervals.   
The second overnight culture of the Group I and Group II strains (I, II) was inoculated 
into deoxygenated TPGY at a ratio of 1:100, mixed, and 350 μl of the inoculated culture 
were transferred as technical replicates into each of four wells of a 100-well microtiter 
plate. The Group I strains (I) were then incubated in the Bioscreen C Microbiology Reader 
at 20 °C for 72 h, at 37 °C for 12 h, and at 42 °C for 12 h, whereas the Group II strains (II) 
were incubated at 10 °C for 14 d, at 30 °C for 48 h, at 37 °C for 48 h, and at 40 °C for 48 
h. The experiment was conducted in quadruplicate (I [37 °C and 42 °C]) or triplicate (I 
[remaining conditions], II).  
The parent and the dnaK and hrcA mutant strains (III) were grown in the Bioscreen C 
Microbiology Reader to test growth behavior at temperature stress in buffered TPGY 
(pH 7) at 37 °C, 42 °C or 45 °C for 14h, to test pH stress at 37 °C in buffered TPGY 
adjusted to pH 5, pH 6, and pH 7.6 for up to 100 h, and to test NaCl stress at 37 °C in 
buffered TPGY with 3% or 3.5% (wt/vol) NaCl added for 24 h. Three biological replicates 
were incubated using three (pH stress) or five (temperature and NaCl stress) technical 
replicates. 
The optical density of the C. botulinum culture was normalized by subtraction of the 
OD600 of inoculated medium from the measured OD600. Growth curves were obtained by 
plotting the measured OD600 against the time. To calculate the maximum growth rates 
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(max GR) of the cultures measured in ODU per hour (ODU/h), their curves were fitted to 
the Baranyi and Roberts model (Baranyi & Roberts, 1994) using the DMFit 2.0 Microsoft 
Excel add-in program (Institute of Food Research, Norwich, UK). The differences 
between the mean maximum growth rates at different temperatures (ΔGR) were calculated 
for each strain by subtraction of their maximum growth rates at the concerned conditions 
from each other (I, II). 
 
 
4.5. Lethal heat stress experiment (III) 
 
The C. botulinum ATCC 3502 parent and hrcA and dnaK mutant strains were 
anaerobically grown until reaching mid-exponential growth phase after inoculation of 100 
μl second overnight culture into 10 ml buffered TPGY broth. After sample withdrawal for 
enumeration the bacterial culture was sealed and exposed to a temperature above 62 °C for 
2 min in a 64 °C water bath. After heat treatment, another sample for enumeration was 
taken. The three-tube most-probable-number approach was used for enumeration of 
bacterial cells to calculate the log reduction in cell number as an indicator of heat 
tolerance of the strains. The three strains with three biological replicates each were heat 
treated simultaneously.  
 
 
4.6. Amplified fragment length polymorphism (AFLP) analysis (II) 
 
The 24 Group II C. botulinum strains used in this study were analyzed using AFLP 
analysis as described by Keto-Timonen et al. (Keto-Timonen et al., 2006). Briefly, 
preselective PCR of HindIII and HpyCH4IV (both New England Biolabs, Beverly, MA) 
digested and HindIII adapter and HpyCH4IV adapter (both Oligomer, Helsinki, Finland) 
ligated DNA samples diluted 1:2 in water was performed in a 20 ml reaction mixture 
using Hind-0 primer and Hpy-0 primer (both Oligomer) (72 °C for 2 min and 20 cycles of 
94 °C for 20 s, 56 °C for 2 min, and 72 °C for 2 min). These templates were then 1:20 
diluted in water and selective PCR amplification was conducted using labeled Hind-C 
primer and Hpy-A primer (both Oligomer)  in a 10 μl reaction mixture: 94 °C for 2 min; 1 
cycle of 94 °C for 20 s, 66 °C for 30 s, 72 °C for 2 min; after this, the annealing 
temperature was lowered for 10 cycles by 1 °C each cycle to reach 56 °C, followed by 
additional 19 cycles at this annealing temperature of 56 °C; and a final 30-min extension 
at 60 °C). An ABI PRISM 310 genetic analyzer (Applied Biosystems, Foster City, CA) 
was used to electrophorese the denatured products of the selective PCR mixed with an 
internal standard on POP-4 polymer (Applied Biosystems) for 28 min at 66 °C and 15 kV.  
The data were processed and analyzed and a dendrogram created using the 
GeneScan 3.7 fragment analysis software (Applied Biosystems) and BioNumerics 
software, version 4.5 (Applied Maths, Kortrijk, Belgium). The strains BL90/4, K8, K35, 
K51, 31-2570, 202, BL86/32, and BL86/34 had been earlier analyzed using the same 
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protocol and instrument (Keto-Timonen et al., 2005) and were therefore included into the 
study without previous reanalyzing.  
 
 
4.7. Construction of mutants (III) 
 
The mutant strains carrying an insertionally inactivated copy of hrcA (cbo2961) or dnaK 
(cbo2959) were constructed from the parental Group I C. botulinum strain ATCC3502 
using the ClosTron gene knock out system as described by Heap et al. (Heap et al., 2007) 
(Table 3). An online re-targeting algorithm (ClosTron, http://www.clostron.com, 
University of Nottingham, Nottingham, United Kingdom) was utilized to identify the 
target sites for the insertion of the mobile group II intron (between nucleotides 53-54 in 
the hrcA and between nucleotides 440-441 in the dnaK gene) and to accordingly design 
suitable mutagenesis plasmids (Table 3) and the primers required to construct them.  
 
 
Table 3.  Mutant, cloning, and donor strains and plasmids used in this study. 
 
Name  Description Source 
Bacterial strains    
C. botulinum ATCC 3502  Parent strain ATCCa 
C. botulinum ATCC 3502 
hrcA::intron-erm 
 ClosTron insertional mutant of 
hrcA in antisense direction 
III 
C. botulinum ATCC 3502 
dnaK::intron-erm 
 ClosTron insertional mutant of 
dnaK in antisense direction 
III 
E. coli TOP10  Electro competent cloning strain Invitrogen, Carlsbad, CA, USA 
E. coli CA434  Conjugation donor strain (Purdy et al., 2002) 
Plasmids    
pMTL007  ClosTron vector for mutagenesis  (Heap et al., 2007) 
pMTL007::CBO2961-53a  pMTL007 targeting hrcA in 
antisense direction 
III 
pMTL007::CBO2959-440a  pMTL007 targeting dnaK in 
antisense direction 
III 
aATCC: American Type Culture Collection, Manassas, Va., USA 
 
 
The mutagenesis plasmids were generated by splice overlap extension PCR according to 
the protocol by Heap et al. (Heap et al., 2007) and ligation of the digested PCR product 
into the plasmid pMTL007. The re-targeted plasmids were cloned in electro competent 
E. coli Top10 cells (Invitrogen, Carlsbad, CA, USA), isolated, and chemically transformed 
into E. coli CA434 donor strains (Purdy et al., 2002). Subsequently the plasmids were 
conjugated into the recipient C. botulinum ATCC 3502. The cells were inoculated on 
TPGY plates supplemented with 15 μg/ml thiamphenicol and 250 μg/ml cycloserine (both 
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Sigma-Aldrich) to select for C. botulinum cells carrying the retargeted plasmid and to 
inhibit growth of remaining E. coli cells. C. botulinum colonies carrying the plasmid were 
picked and grown in TPGY broth supplemented with 15 μg/ml thiamphenicol and 
integration of the mobile group II intron was induced by addition of 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG). TPGY plates containing 2.5 μg/ml erythromycin (Sigma-
Aldrich) were used to select for C. botulinum mutants exhibiting erythromycin resistance 
after successful integration of the intron and activation of its erythromycin resistance gene. 
Intron integration at the desired target site was further confirmed by PCR using target-
gene- and intron-specific primers. 
 
 
4.8. Heat shock experiment, batch culture (III) 
 
The expression of the Class I HSGs grpE (cbo2960), dnaK (cbo2959), dnaJ (cbo2958), 
groES (cbo3299), groEL (cbo3259), and of hrcA (cbo2961), encoding their negative 
regulator, were studied during vegetative growth under optimal conditions and after heat 
shock. A volume of 1 ml second overnight culture of the C. botulinum ATCC parent strain 
or the hrcA mutant strain were inoculated into 250 ml of deoxygenated buffered TPGY 
broth. The cultures were grown anaerobically at 37 °C until reaching mid-exponential 
growth, as indicated by a culture OD600 of 0.9 to 1.1 ODU, and a calibrator sample of 5 ml 
was withdrawn. The parental strain culture to be grown as a control remained at 37 °C and 
further samples were taken 30 min (exponential phase of growth), 1 h 10 min (transition 
phase), 2 h 10 min (early stationary phase), and 5 h 10 min (stationary phase) after 
calibrator sample withdrawal. The parental strain and the hrcA mutant strain cultures to be 
subjected to heat shock were transferred to a water bath set to 65 °C. Immediately after 
reaching a culture temperature of 45 °C, the cultures were moved into an oil bath at 45 °C 
in an anaerobic cabinet (MG1000 Anaerobic Work Station) and a sample was taken (heat 
shock sample, 10 min after the calibrator sample). The cultures remained at 45 °C and 
further samples were withdrawn 20 min, 1 h, 2 h, and 5 h after heat shock, paralleling the 
sample time points of the parental strain grown as a control. The growth experiments were 
carried out in triplicate. 
The culture samples of a volume of 5 ml each were carefully mixed with 1 ml of chilled 
stop solution (900 μl of 99.6% ethanol and 100 μl of phenol [Sigma-Aldrich]) to inhibit 
enzymatic activity, and incubated on ice for 30 min. Then they were aliquoted into 1.5 ml 
volumes and centrifuged for 5 min at 5000 x g at 4 °C. After supernatant removal, the cell 
pellets were stored at -70 °C until RNA extraction. 
 
 
4.9. Heat shock experiment, continuous culture (IV) 
 
To study the whole genome expression profile of the Group I C. botulinum strain 
ATCC 3502 exposed to heat shock and prolonged heat stress, the strain was anaerobically 
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grown in continuous culture in a Braun Biostat B fermenter (B. Braun) in 2 l of buffered 
TPGY broth at 39 °C, at a constant pH of 6.8 maintained by automatic addition of 
3 M KOH (Sigma-Aldrich). The culture was initially inoculated using 10 ml first 
overnight culture. The culture OD600 was automatically continuously measured and 
recorded in absorption units (AU).  Feeding at a dilution rate of 0.035 h−1 was initiated 
after an OD of 1.5 AU was reached. The C. botulinum culture was constantly stirred at 
200 rounds per minute and flushed with N2 to assure anaerobicity. Buffered TPGY for 
feeding was freshly autoclaved and kept anaerobic in airtight containers with N2 overlay. 
Resazurin sodium salt (1 mg/l; Sigma-Aldrich) was used as anaerobicity indicator. The 
foam suppresser Antifoam A (Sigma-Aldrich) was added at a concentration of 20 mg/l to 
the medium.  
After reaching steady-state growth, as indicated by a constant OD600 of 1.6 to 1.7 AU, 
from about 24 h after feeding start onwards, a control sample of 5 ml was withdrawn from 
the bacterial culture and the incubation temperature set to 45 °C. A second sample was 
taken when the culture temperature reached 45 °C 8 min after temperature up-shift 
(defined as heat shock time point). More samples were obtained 10 min and 1 h after heat 
shock, during the adaptation of the culture to 45˚C (18 h and 42 h after heat shock) and 
one last sample was taken after the culture stabilized with new steady stage continuous 
growth at 45˚C (as indicated by a stable OD of 0.7 to 0.8 AU). A volume of 2 ml stop 
solution was added to the culture samples of 5 ml and gently mixed. After incubation for 
30 min on ice, the samples were centrifuged at 5000 x g at 4 °C for 5 min, the supernatant 
removed, and the cell pellet stored at -70˚C until RNA purification. The experiment was 
performed in duplicate, and two technical replicate samples were withdrawn at each time 
point. 
 
 
4.10. RNA isolation (III, IV) 
 
After lysis of the frozen cell pellet for 30 min at 37˚C in 250 μl (III) or 1 ml (IV) lysis 
buffer (25 mg/ml lysozyme and 250 IU/ml mutanolysin [Sigma-Aldrich] in Tris-
Ethylenediaminetetraacetic acid (EDTA) buffer [pH 8.0, Fluka, Biochemica, 
Switzerland]), total RNA was extracted using commercial spin column systems (RNeasy 
Mini (III) or Midi (IV) Kit, Qiagen, Hilden, Germany). Genomic DNA was removed 
during the isolation with an on-column DNase treatment (RNase-Free DNase Set, 
Qiagen), followed by a second DNase treatment after isolation using the Ambion DNA-
free kit (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, USA) 
according to the manufacturer’s instructions. The RNA concentration and quality was 
determined optically by measurement of the absorption units at the wavelength of 260 nm 
(A260) using the NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, 
MA, USA) and by electrophoresis with the 2100 Bioanalyzer using Prokaryote Total RNA 
Nano chips (Agilent Technologies, Santa Clara, CA, United States). 
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4.11. Quantitative real-time reverse transcription PCR (RT-qPCR) 
analysis (III) 
 
An amount of 800 ng total RNA was reverse transcribed into complementary DNA 
(cDNA) using the DyNAmo™ cDNA Synthesis Kit (Finnzymes, Espoo, Finland) 
according to the manufacturer’s instructions. The reverse transcription (RT) reaction was 
carried out in duplicate for each RNA sample to obtain technical replicates. Minus RT 
controls of each RNA sample were obtained by replacement of the reverse transcriptase by 
RNase-free water to control for possible DNA contamination.  
Quantitative real-time PCR (qPCR) reactions were performed in duplicate for each 
cDNA sample using DyNAmo™ Flash SYBR® Green qPCR chemistry (Finnzymes) 
according to the manufacturer’s instructions in a Rotor Gene 3000 Real Time Thermal 
Cycler (Qiagen). Each reaction included 4 μl of diluted cDNA as template, target gene 
specific primers (Table 2 in III) in a final concentration of 0.5 μM, 10 μl 2x DyNAmo™ 
Flash SYBR® Green master mix, and water. The following cycling protocol was applied: 
polymerase activation at 95˚C for 1 min, 40 cycles with 95˚C for 10 sec and 60˚C for 20 
sec with data collection at the end of each cycle, and a final extension step for 1 min at 
60˚C. The primers for quantification of the Class I HSGs (grpE, dnaK, dnaJ, groES, 
groEL, and hrcA) and 16S rrn were designed using the Primer3-web 0.4.0 web-interface 
(http://primer3.sourceforge.net/webif.php) based on the published genome sequence of C. 
botulinum ATCC 3502 (Sebaihia et al., 2007). Reagent contamination was controlled for 
by no-template controls included in each run. Primer specificity was confirmed by melt 
curve analysis at the end of each run. 
For each primer pair, standard curves were constructed using serially-diluted pooled 
cDNA to calculate the amplification efficiency, and to determine suitable sample dilution 
and the quantification threshold for detection of fluorescence above background utilizing 
the Rotor Gene 3000 software version 6.1 (Qiagen). All minus RT controls underwent 
qPCR with melt-curve analysis using 16S rrn primers and none showed evidence for DNA 
contamination of the RNA samples. 
Relative expression values of the Class I HSGs were calculated with the Pfaffl method 
(Pfaffl, 2001) using 16S rrn as the reference gene (Couesnon et al., 2006; Kirk et al., 
2014). The mid-exponential growth phase sample was used as a calibrator to study the 
Class I HSG expression profile of the parent strain during normal growth at 37 °C and of 
the parent as well as the hrcA mutant strain after exposure to heat shock. The mid-
exponential gene expression of the Class I HSGs of the hrcA mutant strain grown at 37 °C 
was calculated relative to that of the wild type strain as calibrator.  
 
 
4.12. DNA microarray analysis (IV) 
 
To study the gene expression profile of the C. botulinum strain, ATCC 3502 custom-
designed, in situ-synthesized DNA microarrays were used (8x15K; Agilent Technologies), 
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which covered 3,641 chromosomal (out of the total of 3,648) and all the 19 plasmid-borne 
CDSs of the bacterium’s genome (Sebaihia et al., 2007; Dahlsten et al., 2014).   
Of each withdrawn sample, 2 μg total RNA was reverse transcribed into cDNA and 
directly labeled with the fluorescent dye Cy3 or Cy5. The RT reaction mixture of 30 μl 
contained 5 μg of random primers, 40 U RNaseOUT™ Recombinant Ribonuclease 
Inhibitor, 6 μl 5x first-strand buffer, 3 μl of 100 mM DTT, 400 U SuperScript™ III 
Reverse Transcriptase (all Invitrogen, Life Technologies Ltd, Paisley, UK), 0.6 μl dNTP 
mix (25 mM dATP, 25 mM dGTP, 25 mM dTTP, 10 mM dCTP [Promega Corporation, 
Madison, WI, USA]), and 2 nmol Cy3-dCTP or Cy5-dCTP (GE Healthcare, 
Buckinghamshire, UK) and was incubated for 3 h at 46˚C. After addition of 1.5 μl 20 mM 
EDTA and 15 μl 0.1 M NaOH, the RNA was hydrolyzed for 15 min at 70˚C. The mixture 
was neutralized by 15 μl of 0.1 M HCl and the labeled synthesized cDNA was 
subsequently purified using a DNA purification column (QIAquick PCR purification kit; 
Qiagen) according to the manufacturer’s instructions, and eluted into 44 μl elution buffer 
(Qiagen).   
Exactly 300 ng of Cy3-labeled and Cy5-labeld cDNA samples each were mixed and 
2.3 μg of salmon sperm DNA (Invitrogen) added followed by denaturation for 2 min at 
95˚C. The samples were cooled on ice and 10x blocking agent and 2x RPMI hybridization 
buffer (both Agilent technologies) were added to the cDNA mixture before loading it onto 
the microarray slide. After hybridization for 16 h at 65˚C, the slides were washed 
according to the manufacturer’s protocol and dried. Reference design was used by 
hybridization of each sample obtained after temperature up-shift against the control 
sample. Dye swap was performed for the technical replicates and dye bias controlled by 
hybridization of differently dyed control samples in one array of each microarray slide. 
The microarray slides were scanned at a wavelength of 532 nm and 635 nm with a 
5 μm resolution in an Axon GenePix Autoloader 4200 AL scanner (Axon Instruments 
Westburg, Leusden, The Netherlands). The Gene Pix Pro 6.0 software (Axon Instruments) 
was utilized for image processing, followed by data analysis with the R limma package 
(Smyth & Speed, 2003; Smyth, 2005). The foreground and local background intensities of 
each spot were identified by the mean and median pixel values of the spot, respectively. 
The “normexp” method, with an offset value of 50, was used to subtract local background 
from the foreground signal (Ritchie et al., 2007). The signal intensities measured in the 
Cy5 and Cy3 channels were converted into a logarithmic (log2) scale and normalized 
using the loess method (Smyth & Speed, 2003). 
 
   
4.13. Statistical analysis (I-IV) 
 
The statistical program SPSS version 15.0 (SPPS Inc., Chicago, IL, USA) was used to 
compare the mean maximum growth rates at the different incubation conditions, Tmin and 
Tmax of the studied Group I and Group II C. botulinum strains, as well as the hrcA and 
dnaK mutant strains (I-III).  
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The differences in the expression values of Class I HSGs obtained by qPCR were 
analyzed using the one-sample t test of the above-mentioned program (III). 
Statistical analysis to study the differences in expression values obtained by DNA 
microarrays were performed with the R limma package (Smyth, 2005) (IV). Each probe 
was analyzed separately using a moderated t test with empirical Bayes variance shrinkage 
(“eBayes” function). The obtained P values were translated into false discovery rate 
(FDR) values using a Benjamini-Hochberg adjustment. The probe with the median 
unmodified P value for the expression difference was chosen to represent the CDS. A 
CDS was considered to be differently expressed at 39 °C and 45 °C and therefore affected 
by high temperature stress when a difference in expression of log2-ratio ≥ 1 or ≤ -1 and 
FDR ≤ 0.05 was detected. 
 CDSs differentially expressed at 39 °C and 45 °C were clustered according to their 
time-dependent expression pattern employing the open source software 
MultiExperimentViewer of the TM4 Microarray Software Suite using the k-means 
clustering method with Euclidean distance (Saeed et al., 2003) (IV).  
 46 
 
5. RESULTS 
 
 
5.1. The strains of C. botulinum vary in growth at low and high 
temperatures 
 
5.1.1. Group I C. botulinum strains (I) 
 
Substantial variation was observed with regard to temperature boundaries for growth and 
growth performance at different incubation temperatures for the 23 Group I C. botulinum 
strains studied (Table 4, Table 2 and 3 in I).  
During 35 days of growth, an average Tmin of 14.5 °C (± 1.2 °C) was detected considering 
all strains, with the lowest Tmin of 12.8 °C and the highest Tmin of 16.5 °C both recorded in 
type B strains (Table 4, Table 2 in I). No significant difference could be found between the 
different toxin types. The average Tmax permitting growth within 48 h was 45.4 °C (± 2.2 
°C), varying from 40.9 to 48 °C between strains (Fig 2). The highest and lowest Tmax were 
observed in type B strains. The average Tmax of the type F strains (42.2 °C) was 
significantly lower than the average Tmax of the other toxin types (P < 0.05). The strains 
belonging to two Nordic type B clusters differed significantly in their Tmin as well as their 
Tmax between the two clusters (P < 0.05). Cluster II had a lower Tmin and cluster I a higher 
Tmax (Table 2 in I). The strain variation within a serotype was highest for the type B 
strains, whereas the type A strains exhibited the widest temperature range allowing 
growth. 
 
Table 4. Average minimum (Tmin) and maximum (Tmax) growth temperatures, maximum growth 
rates at 20 °C (max GR 20), 37 °C (max GR 37), and 42 °C (max GR 42), and differences between 
growth rates at 20 and 37 °C (ΔGR20-37) and at 42 and 37 °C (ΔGR42-37) of the studied 23 
Group I C. botulinum strains of serotype A, AB, B, and F. Lowest and highest values obtained 
within the serotype in brackets.  
 
 Growth characteristic 
Type A 
n = 5 
Type AB 
n = 2 
Type B 
n = 14 
Type F 
n = 2 
All 
n = 23 
 Av Tmin (°C)  
14.4 
(13.3 - 15.0) 
14.1 
(13.8 - 15.0) 
14.5 
(12.8 - 16.5) 
15.0 
(14.4 - 15.7) 
14.5 
(12.8 - 16.5) 
 Av Tmax (°C) 
46.5 
(45.6 - 47.5) 
45.5 
(44.7 - 46.4) 
45.5 
(40.9 - 48.0) 
42.2 
(41.4 - 42.9) 
45.4 
(40.9 - 48.0) 
 Max GR 20 (ODU/h) 
0.09 
(0.07 - 0.10) 
0.06 
(0.05 - 0.07) 
0.07 
(0.04 - 0.10) 
0.06 
(0.05 - 0.08) 
0.07 
(0.04 - 0.10) 
 Max GR 37 (ODU/h) 
0.44 
(0.39 - 0.51) 
0.58 
(0.57 - 0.59) 
0.52 
(0.31 - 0.62) 
0.36 
(0.34 - 0.37) 
0.49 
(0.31 - 0.62) 
 Max GR 42 (ODU/h) 
0.35 
(0.11 - 0.50) 
0.54 
(0.51 - 0.57) 
0.47 
(0.06 - 0.67) 
0.04 
(0.02 - 0.06) 
0.41 
(0.02 - 0.67) 
 ΔGR20-37 (ODU/h) -0.35 (-0.43 - -0.30) 
-0.52 
(-0.54 - -0.50) 
-0.45 
(-0.52 - -0.36) 
-0.29 
(-0.33 - -0.26) 
- 0.42 
(-0.54 - -0.26) 
 ΔGR42-37 (ODU/h) -0.09 (-0.28 – 0.04) 
-0.03 
(-0.07 – 0.0) 
-0.05 
(-0.39 – 0.09) 
-0.32 
(-0.35 - -0.28) 
-0.08 
(-0.39 – 0.09) 
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The average max GR of all studied Group I C. botulinum strains was 0.07 ODU/h 
(± 0.02 ODU/h) at 20 °C, 0.49 ODU/h (± 0.09 ODU/h) at 37 °C, and 0.41 ODU/h (± 0.24 
ODU/h) at 42 °C (Table 4, Table 3 in I). They varied from 0.05 to 0.10 ODU/h at 20 °C, 
from 0.31 to 0.62 ODU/h at 37 °C, and from 0.02 to 0.67 ODU/h at 42 °C (Table 4). The 
lowest max GR for type F strains was found at 42 °C, whereas the other toxin types grew 
on average slowest at 20 °C. At 20 °C, Nordic cluster II strains showed significantly 
higher max GR than cluster I strains (P < 0.05) (Table 3 in I). Altogether eight strains had 
a significantly higher max GR at 42 °C than at 37 °C (ΔGR42-37) (P < 0.05); all of them 
were type B strains. 
There was significant correlation between the Tmax and the ΔGR42-37 taking into 
account all 23 Group I C. botulinum strains (r = 0.82, P < 0.01) (Fig. 2), however, no 
correlation was detected considering only type A strains. No correlation between Tmin and 
ΔGR20-37 was observed. Of the eight type B strains with higher max GR at 42 °C 
compared to 37 °C, one strain had a lower than average Tmax.  
 
 
 
 
Figure 2. Relationship between the maximum growth temperature (Tmax) and the difference 
between maximum growth rates at 42 °C and 37 °C (ΔGR42-37) for 23 Group I C. botulinum 
strains of serotype A (open triangles), AB (filled triangles), B (asterisks), and F (open squares). The 
y-axis crosses the x-axis at the average Tmax calculated from all strains. 
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5.1.2. Group II C. botulinum strains (II) 
 
As for Group I, the 24 Group II C. botulinum strains also demonstrated significant 
variation in growth characteristics at extreme temperatures (Table 5, Table 2 and 3 in II). 
The average Tmin promoting growth within 28 d of incubation was 7.3 °C (± 0.7 °C), 
with the low temperature growth boundaries of the strains varying from 6.2 to 8.6 °C 
(Table 5, Table 2 in II). The type F strains showed, with 7.8 °C, a significantly higher 
average Tmin than the type B and E strains (P < 0.05); the largest strain variation within a 
toxin type was found for the type E strains. The average of all the studied 24 Group II C. 
botulinum strains’ Tmaxs was 38.5 °C (± 1.2 °C); they ranged from 34.7 to 39.9 °C. 
Comparing the toxin types, the type E strains showed the significantly highest average 
Tmax (P < 0.05), with 39.0 °C.  Type B strains had the largest variation within a toxin type 
and additionally exhibited the widest temperature range permitting growth on average. 
Average max GRs of all studied Group II C. botulinum strains of 0.02 ODU/h (± 0.01 
ODU/h) at 10 °C, of 0.36 ODU/h (±0.04 ODU/h) at 30 °C, of 0.25 ODU/h (±0.11 ODU/h) 
at 37 °C, and of 0.06 ODU/h (±0.05 ODU/h) at 40 °C were obtained. However, only 11 
type E strains were able to grow at a temperature as high as 40 °C in TPGY broth (Table 
5, Table 3 in II). The max GRs varied from 0.01 - 0.05 ODU/h at 10 °C, from 0.29 - 0.44 
ODU/h at 30 °C, from 0.08 - 0.45 ODU/h at 37 °C, and from 0.00 - 0.14 ODU/h at 40 °C 
(Table 5). 
 
 
Table 5. Average minimum (Tmin) and maximum (Tmax) growth temperatures, maximum growth 
rates at 10 °C (max GR 10), 30 °C (max GR 30), 37 °C (max GR 37), and 40 °C (max GR 40), and 
differences between growth rates at 10 and 30 °C (ΔGR10-30) and at 37 and 30 °C (ΔGR37-30) of 
the studied 24 Group II C. botulinum strains of serotype B, F, and E. Lowest and highest values 
obtained within the serotype in brackets. NG: no growth observed.  
 
 Growth characteristic 
Type B 
n = 3 
Type E 
n = 16 
Type F 
n = 5 
All 
n = 24 
 Av Tmin (°C)  
7.0  
(6.2 – 8.0) 
7.1 
(6.3 – 8.6) 
7.8 
(7.1 – 8.4) 
7.3 
(6.2 – 8.6) 
 Av Tmax (°C) 
36.6 
(34.7 – 38.5) 
39.0 
(37.4 – 39.9) 
37.8 
(37.0 – 38.6) 
38.5 
(34.7 – 39.9) 
 Max GR 10 (ODU/h) 
0.03 
(0.01 - 0.05) 
0.02 
(0.01 - 0.04) 
0.02 
(0.01 - 0.04) 
0.02 
(0.01 - 0.05) 
 Max GR 30 (ODU/h) 
0.38 
(0.35 - 0.40) 
0.36 
(0.29 - 0.44) 
0.35 
(0.30 - 0.41) 
0.36 
(0.29 - 0.44) 
 Max GR 37 (ODU/h) 
0.11 
(0.08 - 0.20) 
0.30 
(0.18 - 0.45) 
0.16 
(0.09 - 0.23) 
0.25 
(0.08 - 0.45) 
 Max GR 40 (ODU/h) NG 
0.06 
(0.01 - 0.14) NG 
0.06 
(0.00 - 0.14) 
 ΔGR10-30 (ODU/h) 
-0.35 
(-0.39 - -0.30) 
-0.34 
(-0.40 - -0.28) 
-0.33 
(-0.40 - -0.28) 
- 0.34 
(-0.40 - -0.28) 
 ΔGR37-30 (ODU/h) 
-0.26 
(-0.30 – -0.20) 
-0.06 
(-0.18 - 0.05) 
-0.20 
(-0.25 - -0.13) 
-0.11 
(-0.25 - 0.05) 
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The average max GR at 37 °C of the type E strains was significantly higher than of the 
other toxin types (P < 0.05). Further, five type E strains showed a higher max GR at 37 °C 
compared to 30 °C, however, this difference was statistically non-significant. 
Taking all strains into consideration, a significant correlation between the Tmax and the 
difference between max GR at 37 and 30 °C was found (r = 0.85, P < 0.05) (Fig. 3). The 
five strains which grew faster at 37 °C than at 30 °C exhibited a higher than average Tmax. 
Determination of the genetic background by AFLP clustering (Fig. 4 in II) divided the 
studied Group II C. botulinum strains into two type E clusters (cluster I and II) and one 
cluster consisting of type B and F strains (cluster III). The clusters reflected poorly in 
temperature-related growth behavior of the strains, nevertheless, type E cluster I strains 
showed a significantly higher max GR at 10 °C than cluster II strains (P < 0.05).   
 
 
 
 
Figure 3. Relationship between the maximum growth temperature (Tmax) and the difference 
between maximum growth rates at 37 °C and 30 °C (ΔGR37-30) for 24 Group II C. botulinum 
strains of serotype B (asterisks), E (filled squares), and F (open squares). The y-axis crosses the x-
axis at the average Tmax calculated from all strains. 
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5.2. The role of Class I HSGs in heat shock as well as pH and 
NaCl stress response in Group I C. botulinum (III) 
 
5.2.1. Relative expression of Class I HSGs  
 
During the exponential and the transition growth phase at 37 °C, the parent C. botulinum 
strain ATCC 3502 showed only marginal changes in expression of the Class I HSGs hrcA 
(cbo2961), grpE (cbo2960), dnaK (cbo2959), dnaJ (cbo2958), groES (cbo3299), and 
groEL (cbo3259), whereas significant down-regulation was observed at the later time 
points (Fig. 3 in III). Exposure to heat shock by temperature up-shift to 45 °C during mid-
exponential growth led to an immediate 3- to 11-fold activation of all Class I HSGs 
(Fig. 4A). Of these, only the groELS operon remained 5-fold up-regulated 1 h after 
temperature up-shift. In the stationary phase, all studied genes were expressed at lower 
levels than at the earlier time points. The relative gene expression was compared to mid-
exponential growth at 37 °C.  
During mid-exponential growth at 37 °C, the hrcA mutant expressed all Class I HSGs 
at a more than two-fold higher level than the parent strain (Fig. 5 in III). After heat shock, 
activation of the groELS operon was observed for 1 h, whereas the dnaK operon remained 
unaffected (Fig. 4B). 
 
 
Figure 4. Relative expression 
ratios of hrcA, grpE, dnaK, dnaJ, groES, 
and groEL at different time points after 
heat shock (HS) at 45 °C compared to 
pre-heat shock, mid-exponential growth 
of the C. botulinum ATCC 3502 wild type 
(A) and the hrcA mutant at 37 °C (B). The 
16S rrn was used as a normalization 
reference. The error bars indicate the 
variations of three biological replicates. 
Relative expression ratios that differ 
significantly from 1 (P < 0.05) are marked 
with an asterisk.  
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5.2.2. Characterization of mutant strain growth  
 
Both mutant strains carrying the insertionally-inactivated dnaK or hrcA gene showed 
impaired growth and viability compared to the wild type under most tested growth 
conditions. 
The high temperature growth boundary of both mutants was significantly reduced 
compared to the parent strain (P < 0.05), with the hrcA mutant exhibiting a 0.9 °C and the 
dnaK mutant a 5.1 °C lowered Tmax (Fig. 7 in III).  
Even though reduced growth of the hrcA mutant was observed under most tested 
conditions, no significant difference between its max GR during growth at 42 °C or at 
pH 6 could be detected compared to the parent strain (Fig. 5). The growth of the dnaK 
mutant was significantly impaired at all tested conditions (P < 0.05).  
Both mutants showed increased sensitivity to lethal heat stress. Whereas the applied 
heat treatment of 64 °C led to a 3.6 log reduction in cell number in the parent strain, the 
viable cell number of the hrcA mutant decreased by 5.1 log in and of the dnaK mutant by 
8.2 log (Fig. 8 in III).  
 
 
 
Figure 5. Growth curves of the C. botulinum ATCC 3502 wild type (open circles), hrcA mutant 
(open squares), and dnaK mutant (open triangles) at the indicated pH values and temperatures in 
buffered TPGY broth (A to F) or in TPGY broth with added NaCl (G and H). The error bars indicate 
the variations of three biological replicates.  
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5.3. The transcriptional response to heat shock and prolonged 
heat stress of Group I C. botulinum grown in continuous 
culture(IV)  
 
Exposure of the continuously-grown C. botulinum to heat shock from 39 to 45 °C led to a 
drop in culture OD600 from 1.6 to 1.7 AU before heat treatment to approximately 0.7 AU 
when adapted to high temperature (Fig. 1 in IV). This exposure to high temperature 
resulted in significant changes in the transcription of a large proportion of genes soon after 
heat shock, during the adaptation to high temperature and in the continuous culture 
adapted to 45 °C (Fig. 2 in IV). 
The expression of many genes related to transcription and translation was transiently 
suppressed compared to growth at 39 °C, as an early response to temperature up-shift. 
Amongst these were genes coding RNA polymerase proteins, 30S or 50S ribosomal 
proteins, aminoacyl tRNA synthetases, and translation initiation as well as elongation 
factors (Table 1 in IV). In contrast, Class I and most Class III heat shock, as well as some 
SOS response related, genes were activated shortly after heat shock. 
All genes coding for the proteins of the neurotoxin complex including botA were found 
to be suppressed from 10 min of growth at 45 °C onwards, being expressed at a 5- to 7-
fold lower level 1 h after heat shock compared to before. They remained expressed at low 
level throughout the experiment, whereas no such suppression could be detected for their 
positive regulator botR (Table 1 in IV). 
Prolonged high temperature stress resulted in down-regulation of the majority of 
sporulation-related genes in continuously-grown C. botulinum, including the sporulation 
related RNA polymerase sigma factor coding genes sigG, sigE, sigF, and sigK. Many of 
these genes were suppressed from as early as 1 h after heat shock onwards, whereas down-
regulation of their master regulator Spo0A coding gene was observed only in the heat-
adapted culture. In contrast, increased transcription of the majority of chemotaxis and 
motility-related genes was detected as a response to long-term exposure to high incubation 
temperature. However, some of these genes were transiently suppressed 1 h after heat 
shock, amongst these were the flagellar-specific polymerase sigma factor coding gene 
sigD and several genes coding for flagellin, the main structural component of the bacterial 
flagella (Table 1 in IV). 
Both major loci of genes assigned to be related to phage and IS elements were affected 
by temperature stress. The first locus was up-regulated predominantly during the adaption 
and in the heat-adapted culture. The second locus was expressed differently; a large part of 
it was activated by heat already 1 h after heat shock, whereas the remaining part was 
suppressed at high temperature. Amongst the up-regulated genes of the second locus were 
a RNA polymerase sigma factor coding gene and other genes related to transcriptional 
regulation. 
Genes related to the acetone-butanol-ethanol fermentation pathway were also affected 
by high temperature stress. The fermentation pathway to convert actetyl-CoA to butyryl-
CoA, the basic compound for butanol and butyrate production, was strongly down-
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regulated during heat stress, whereas the gene coding for aldehyde-alcohol dehydrogenase 
was up-regulated. In addition, a number of genes related to the metabolism and transport 
of the carbohydrates glycerol, sorbitol, and trehalose were activated by heat (Table 1 
in IV).  
The C. botulinum cells responded to heat stress with reduced transcription of genes 
coding secreted proteases throughout the experiment. Further, a suppression of genes of 
the leucine and phenylalanine metabolism pathways upon heat shock was found. Of these, 
the leucine-related genes remained suppressed, whereas the phenylalanine-related genes 
were activated at later time points. Genes for the proline reductase complex were also 
activated at the late time points, whereas glycine reductase complex genes were transiently 
suppressed after heat shock. Further, a number of genes related to the biosynthesis of the 
sulfur-containing amino acids, cysteine and methionine, were found to be induced by heat.  
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6. DISCUSSION 
 
 
6.1. Variation between strains of C. botulinum regarding growth 
at low and high temperatures (I, II) 
 
Unexpectedly large strain variation was found with regard to temperature boundaries for 
growth and growth performance at different temperatures amongst the 23 Group I and the 
24 Group II C. botulinum strains included in the studies. 
The Tmin and Tmax variation within Group I strains (12.8 to 16.5 °C and 40.9 to 48 °C, 
respectively) was higher than within Group II strains (6.2 to 8.6 °C and 34.7 to 39.9 °C, 
respectively). This finding was interesting in light of the genetic background the strains 
reflected: when studied by AFLP analysis, Group I strains clustered more closely together 
than Group II strains, indicating their lower genetic diversity (Keto-Timonen et al., 2005; 
Keto-Timonen et al., 2006). This knowledge could lead to the assumption that the Group I 
strains, being more closely related, would also be physiologically more similar compared 
to Group II strains. This assumption could not be supported in terms of growth-limiting 
temperatures for the studied strains.  
In general, the genetic background of the Group I and the Group II strains included in 
the studies failed to reflect well in their growth behavior at stressful temperature. This 
finding has been recently confirmed for Group II C. botulinum with regard to Tmin 
(Stringer et al., 2013). In Group I and Group II, relatively closely genetically-related 
strains possessing significantly different growth traits were found. Nevertheless, Group I 
C. botulinum strains representing the Nordic type B cluster I or II (Nevas et al., 2005; 
Lindström et al., 2009) showed very similar growth limits within, and significantly 
different limits between, the genetic clusters, with cluster II strains showing more 
psychrotrophic tendencies with lower Tmins and higher max GRs at 20 °C. These two 
clusters have also been shown to differ in their cadmium and arsenic resistance (Lindström 
et al., 2009).   
In both Group I and Group II, strains were found that grew faster at temperatures 
higher than at their expected optimum growth temperatures (Lindström & Korkeala, 
2006). Eight Group I type B strains grew significantly faster at 42 than at 37 °C and five 
Group II type E strains grew faster at 37 than at 30 °C. Most of these strains also exhibited 
a Tmax above the average of all strains and thus appeared to tolerate high temperature 
better than other strains. These observations indicate that the optimal growth temperature 
for many Group I and Group II C. botulinum strains may actually be noticeably higher 
than commonly expected. Interestingly, one Group I type B strain growing faster at the 
higher temperature had a Tmax lower than average. In contrast, three type A strains with 
high Tmax grew faster at 37 than at 42 °C and also the type E strain with the highest Tmax 
grew faster at 30 than at 37 °C. These findings emphasize that, even though good 
correlation between growth characteristics at high temperature was found, on an individual 
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strain level, prediction from one growth trait to another may not be possible and lead to 
underestimation of risks.  
Within Group II, the type E toxin-producing strains appeared to tolerate high 
temperature better than type B or F strains. The only strains able to grow at 40 °C in broth 
were type E strains, they showed the highest average GR at 37 °C, and five of them grew 
faster at 37 than at 30 °C, the commonly-quoted optimal growth temperature for Group II 
C. botulinum (Lindström & Korkeala, 2006; Carter & Peck, 2015). Therefore the type E 
strains seemed to show a more mesophilic growth tendency.  
Even though C. botulinum type E strains have a high prevalence in fish and the fish-
production environment (Huss, 1980; Hielm et al., 1998a; Hyytiä et al., 1998), they 
account for only a relatively small number of botulism outbreaks related to commercial 
food (Korkeala et al., 1998; King et al., 2009). The results indicate that commonly-
recommended storage temperatures and times may be sufficient to prevent type E toxin 
formation of most strains in fishery products. Nevertheless, the studied Group II strains do 
pose a special risk in REPFEDs. For all of them, a Tmin permitting growth below 9 °C, a 
temperature frequently found in household refrigerators (James et al., 2008), was found. 
Larger variation in the studied growth characteristics at high temperature than at low 
temperature was detected. This is in accordance with a study examining the probability of 
growth of C. botulinum, which found a larger variation amongst Group I strains at 47 °C 
than at 12 °C (Jensen et al., 1987). Larger strain variation at high temperature has also 
been described for other foodborne pathogens like E. coli and B. cereus (Membré et al., 
2005). The temperature dependence of protein structure and thus temperature sensitivity of 
enzymes is a possible explanation for this finding (Dobson, 2003; Richter et al., 2010). At 
high temperature, conformational changes in protein structure can hamper their function, 
which in turn might inhibit bacterial growth. Differences in protein and enzyme 
composition of individual C. botulinum strains and possibly even small alterations in 
amino acid sequences could therefore lead to differences in temperature sensitivity and in 
growth characteristics between strains, especially at stressful high temperature.  
Distinct strain variation was observed with regard to growth at stressful temperatures 
for C. botulinum strains. Furthermore, the possibility of higher-than-assumed optimal 
growth temperatures, as well as the difficulty to predict the studied growth traits for 
individual strains was shown. These findings must be carefully taken into consideration 
when applying risk-assessment methods and designing challenge studies to evaluate the 
safety of food products with regard to C. botulinum (Wachnicka, 2014). 
 
 
 
6.2. Importance of Class I HSGs in stress response in Group I 
C. botulinum (III) 
 
After exposure of batch-culture grown C. botulinum ATCC 3502 to heat shock from 37 
to 45 °C, transiently-induced expression of the two Class I HSG operons dnaK and 
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groELS was observed. Class I HSGs code for molecular chaperones (Sebaihia et al., 
2007), which assist protein folding and are negatively regulated by HrcA in B. subtilis 
(Schulz & Schumann, 1996). Activation of these genes has recently been reported for 
C. botulinum 15 min after heat shock using a genome-wide gene expression profile 
approach with DNA microarrays (Liang et al., 2013) and is in agreement with the earlier 
reported increase of DnaJ protein expression in C. botulinum after heat shock (Shukla & 
Singh, 1999). Activation of Class I HSGs for 20 min (dnaK operon) up to 1 h (groELS 
operon) after heat shock was detected here (Study III), which was considerably longer 
than reported for B. subtilis (Schmidt et al., 1992; Wetzstein et al., 1992). Similar 
observations have been made for C. acetobutylicum (Narberhaus & Bahl, 1992; 
Narberhaus et al., 1992). This indicates that Class I HSG encoded molecular chaperones 
may play a more important role in the heat stress response of clostridia than in other 
Gram-positive bacteria, which could be explained by their need to compensate the lack of 
homologs of SigB regulated Class II HSGs of the B. subtilis (Hecker et al., 2007). 
The insertional inactivation of hrcA in Study III resulted in over-expression of Class I 
HSGs during mid-exponential growth similar to B. subtilis (Schulz & Schumann, 1996) 
and therefore confirmed its predicted function as negative regulator of Class I HSGs in 
C. botulinum (Sebaihia et al., 2007). Interestingly, heat shock led to further activation of 
the groELS operon in the mutant, whereas the dnaK remained unaffected. This observation 
and the fact that heat shock led to a longer activation of the groELS than the dnaK operon 
in the wild type strain indicate the presence of a further, currently-unknown regulatory 
pathway for the groELS operon. However, no consensus site for SigK, which was 
identified in a type D strain (Sagane et al., 2003), could be detected upstream of the 
groELS operon in C. botulinum ATCC 3502. 
The mutant strains carrying the insertionally inactivated hrcA or dnaK gene were viable 
under most tested conditions, however showed limitations in their growth performance, 
reduced recovery after lethal heat stress, and a lower Tmax compared to the parental strain. 
The dnaK mutant was more strongly restricted in its growth than the hrcA mutant under all 
tested conditions. This highlights the importance of functional dnaK for C. botulinum for 
growth under stressful, but also under optimal growth conditions, similar to E. coli and B. 
subtilis (Paek & Walker, 1987; Schulz et al., 1995). The molecular chaperone DnaK is 
involved in correct folding of nascent proteins during normal cell growth and in repair and 
stabilization of denatured proteins (Schröder et al., 1993; Hartl & Hayer-Hartl, 2002) and 
therefore plays a major role in bacterial survival, especially under heat stress resulting in 
protein denaturation.  
Under optimal growth conditions (pH 7.0 at 37 °C) the hrcA mutant strain showed a 
gently-reduced maximum GR. But interestingly, during growth under mild stress 
conditions (42 °C or pH 6.0), no significant difference was detected compared to the 
parental strain. This observation could be explained by a possible positive effect of 
continuously over-expressed Class I HSGs, leading to elevated levels of molecular 
chaperons in the bacterial cell. These might promote bacterial growth under mild stress 
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conditions. However, when exposed to more severe environmental stress, the inability of 
the hrcA mutant to further activate the dnaK operon resulted in impaired growth. 
Both mutant strains showed restricted growth under increasing acidic and osmotic 
stress. The involvement of Class I HSGs in the response of C. botulinum to environmental 
stresses other than heat resulting in intracellular accumulation of denatured and aggregated 
protein seems likely. Similarly, the cold shock genes of C. botulinum have been observed 
to respond to other stresses (Derman et al., 2015). Exposure to high temperature of 
B. subtilis and a number of foodborne pathogens has been shown to be able to lead to 
cross-protection against other stresses (Volker et al., 1992; Wesche et al., 2009). This is 
an important factor when considering the role of C. botulinum as a foodborne pathogen. 
Exposure to mild, sublethal stresses during food processing might result in activation of 
the molecular chaperone system and subsequently protect C. botulinum from other 
stresses, especially when applying hurdle technology as a food safety measure.  
 
 
6.3. Modulation of gene expression patterns of Group I 
C. botulinum grown in continuous culture after heat shock 
and during adaptation to high temperature (IV) 
 
The transcriptomic analysis of continuously-grown C. botulinum ATCC 3502 exposed to 
heat shock at 45 °C showed transient suppression of transcription- and translation-related 
genes within 1 h, indicating a temporary growth arrest of the culture. Liang et al. (2013) 
made a similar observation at the transcriptional level by 15 min after heat shock of mid-
exponential C. botulinum batch culture, but this change was not detected by OD 
measurements in study III. The activation of Class I HSGs, which have been related to 
heat shock response in C. botulinum earlier (study III), Class III HSGs, and SOS response 
genes further proved induction of a heat shock response in this experimental set up.  
Down-regulation of botA and the ANTP coding genes was observed from 10 min after 
heat shock, persisting throughout the experiment. BoNT expression therefore seemed to be 
suppressed at the transcriptional level in heat-stressed C. botulinum. This finding is in 
agreement with an early study detecting reduced toxin levels in C. botulinum culture 
grown in a fermenter at 45 °C (Siegel & Metzger, 1979), but contrasts reports that no 
differences in BoNT levels or botA transcription levels were identified comparing batch 
culture grown C. botulinum at 37 and 44 °C (Couesnon et al., 2006). However, it seems 
reasonable that cellular functions ensuring survival might be prioritized over dispensable 
processes with high energy costs like large toxin complex production when bacteria are 
exposed to severe stress. The impact of growth phase and environmental influences (like 
lack of nutrients, changes of pH, or other factors involved in toxin production by 
C. botulinum when grown in batch culture) have been minimized by the experimental set 
up, which could serve as an explanation for this apparent discrepancy. Interestingly, botR, 
the positive regulator of toxin expression (Marvaud et al., 1998), showed mild activation, 
underlining the presence of a botR-independent active negative regulatory network 
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controlling botA expression, most likely in response to environmental stimuli. 
Unfortunately, there was insufficient data for the only identified negative regulator of 
toxin expression (Zhang et al., 2013). However, the transcription of several genes for TCS 
and transcriptional regulators was affected by heat stress, which might serve as a basis for 
future studies.  
Sporulation is an efficient measure that bacteria employ to withstand adverse 
environmental conditions, since spores are extremely resistant to heat, desiccation, UV-
light, and radiation (Stephens, 1998). It has been linked to toxin production in some 
pathogenic clostridia (Li & McClane, 2010; Saujet et al., 2011; Al-Hinai et al., 2015). 
Surprisingly, suppression of the majority of sporulation genes, including sporulation-
related RNA polymerase sigma factor coding genes, was observed especially during 
adaptation and in the heat-adapted continuous C. botulinum ATCC 3502 culture. 
Apparently, sporulation is not utilized in the heat stress response of C. botulinum. Reduced 
expression of sporulation-related genes has also been observed in B. subtilis exposed to 
secretion stress (Lulko et al., 2007). One reason might be that spores formed under heat 
stress most likely contain high levels of damaged proteins and DNA. They might therefore 
be dysfunctional, unable to germinate or outgrow into culture. Further, heat stressed 
C. botulinum cells might not be able to form spores due to impaired proteins in the spore 
formation apparatus or lack of metabolic resources. Sporulation might thus be an 
inappropriate survival mechanism if spores are produced under severe heat stress.  
Chemotaxis- and motility-related genes were activated during the adaptation and in the 
continuous C. botulinum culture adapted to heat. Increase in motility to possibly occupy 
more favorable environmental niches can serve as an alternative survival strategy in 
bacteria (Stephens, 1998). Sporulation and motility, both growth-phase dependent during 
batch culture growth of bacteria, appeared to be oppositely regulated in response to heat 
stress in C. botulinum. This regulation pattern has been previously described in different 
bacteria (Aizawa et al., 2002; Tomas et al., 2003; Lulko et al., 2007) and has been related 
in B. subtilis to lack of competition for SigD, the motility-related sigma factor, due to 
reduced expression of sporulation-related sigma factors (Lulko et al., 2007). In contrast, 
the non-spore-forming L. monocytogenes and E. coli exhibit a non-motile phenotype at 
high temperature (Griffin & Robbins, 1944; Li et al., 1993). Interestingly, 1 h after heat-
shock reduced transcription was detected for sigD, encoding the above-mentioned sigma 
factor, and several flagellin coding genes. Their activation at later time points might 
suggest that increase in motility and flagella serves as a longer term mechanism to adapt to 
high temperature rather than as an acute heat shock response. Since flagella synthesis is a 
highly energy-consuming process, this observation seems biologically reasonable.  
A large proportion of the genes on the two C. botulinum ATCC 3502 prophages were 
activated by heat, most strongly during the adaptation and in the heat-adapted culture, but 
many of them already soon after heat shock. Heat induction of the lytic cycle as reported 
for E. coli and B. subtilis (Lieb, 1964; Armentrout & Rutberg, 1971) seems unlikely, 
however, since most structural prophage genes were not induced. Interestingly, a number 
of regulatory genes encoded from the prophages, including an RNA polymerase sigma 
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factor coding gene, were activated. Lysogenic phages, which are integrated into the host 
genome can contribute to fitness and pathogenicity of the bacterial host by transfer of 
beneficial genes (Brussow et al., 2004; Fortier & Sekulovic, 2013). Interestingly, a 
prophage-encoded sigma factor has been related to increased viability and biofilm 
formation in B. anthracis (Schuch & Fischetti, 2009). The prophages of C. botulinum 
ATCC 3502 appear to be unique for this strain (Sebaihia et al., 2007). Therefore unique 
prophage-encoded regulatory genes might affect the phenotype of this particular strain and 
even account for its relatively high temperature tolerance as shown by the high Tmax 
compared to other Group I strains (I).  
Many genes related to energy metabolism of C. botulinum showed changes in their 
expression after heat shock. Genes of the acetone-butanol-ethanol fermentation pathway, 
that have recently been shown to play a role in the cold tolerance of C. botulinum 
(Dahlsten et al., 2014), were strongly suppressed from 1 h after heat shock onwards, most 
likely leading to reduced butanol and butyrate levels in the culture. Butyrate has been 
reported to induce toxin synthesis in C. difficile (Karlsson et al., 2000). Lowering butyrate 
levels in the culture during heat stress might therefore have an impact on toxin production 
in C. botulinum as well. The proteolytic activity of the culture appeared reduced as 
secreted protease coding genes were suppressed soon after heat shock and remained down-
regulated. Further, changes in expression levels of genes related to fermentation of amino 
acids by the Stickland reaction (Stickland, 1934; Sebaihia et al., 2007), genes related to 
the metabolism of sulfur containing amino acids, and the corresponding amino acid 
transporters were observed in response to heat stress. All these findings indicate dramatic 
changes in the energetic status of the C. botulinum cell when exposed to heat stress. 
Interestingly, a link between BoNT production and cell metabolism has been recently 
made as CodY, coding a GTP-sensing global regulator, has been identified as a positive 
regulator of botA expression (Zhang et al., 2014). However, deeper understanding of the 
connection between BoNT production and energy metabolism in C. botulinum requires 
further investigation. 
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7. CONCLUSIONS 
 
 
1. Group I and Group II C. botulinum strains varied significantly within their groups 
with relation to growth-limiting temperatures and their capability to grow at 
extreme temperatures. This strain variation was particularly large at high 
temperature. In both groups, strains with considerably high Tmax were detected. 
Most of these strains also grew faster at high incubation temperature and are 
therefore expected to have optimal growth temperatures clearly above the 
commonly quoted optimum. Even though good correlation between Tmax and 
growth rates at high temperature was detected, a number of strains for which this 
did not apply were found. Therefore prediction from one growth trait to another 
appears to be difficult, especially at high temperature. These observations are of 
significance with regard to the development of risk assessment methods and the 
design of challenge studies to estimate the risk of C. botulinum growth and BoNT 
production in food.  
 
2. The Group I C. botulinum strain ATCC 3502 employed Class I HSGs in the acute 
response to heat stress. The annotated role of HrcA as the negative regulator of 
these genes has been confirmed as a mutant strain harboring an insertionally-
inactivated hrcA gene significantly over-expressed Class I HSGs. The importance 
of the molecular chaperone DnaK in the growth of C. botulinum in optimal and 
stressful conditions has been demonstrated, as a mutant carrying an insertionally-
inactivated dnaK gene showed impaired growth characteristics in all tested 
conditions. Both mutant strains were growth restricted, not only under heat stress, 
but also under acidic and saline stress. This finding indicates that heat activation of 
Class I HSGs could lead to subsequent cross-protection against other stresses, 
which might be of relevance in terms of food safety when hurdle technology is 
applied to prevent growth of C. botulinum. 
 
3. During acute heat stress, continuously grown C. botulinum ATCC 3502 utilized 
genes of the SOS response system in addition to Class I and Class III HSGs during 
heat shock response. High temperature led to reduced expression of botA, as well 
as ANTP coding genes under the tested conditions. No initiation of production of 
dormant spores as a survival strategy against heat stress was observed in 
C. botulinum, whereas lasting activation of motility-related genes indicated an 
attempt of the culture to migrate towards a more beneficial growth environment. 
Many prophage genes were over-expressed under heat stress; these unique 
prophages might therefore contribute to relatively high heat tolerance of the strain. 
Intensive metabolic remodeling was associated with the heat stress response, 
especially in the long-term adaptation to heat in continuously-grown C. botulinum, 
and might influence the culture’s ability to form BoNT. 
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